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INTRODUCTION 
Plants have been using by humans since the age of primitive man. The 
primitive man had several opportunities to study the Plants, Minerals, Animal sources 
in several aspects which they used to overcome diseases and lead a healthy life.
[1] 
Usage of medicinal plants was disappeared in recent past and nowadays it regains its 
importance among the population. India is blessed with rich flora, which can be 
harnessed to treat diseases through right knowledge. Herbs are the main source for 
traditional medicines along with metals and minerals.  
There are many traditional medicines exist in the world that uses plant and 
animal sources for preparing medicines, among which Siddha medicine is unique. The 
word Siddha means “Siddhi” namely spiritual power. All siddhars had this power. 
The traditional Siddha system of medicine is based on 96 thathuvas [or] principles. It 
includes mainly Tridosas & Panchabhutha theory. According to Siddha system of 
medicine, health is defined as the state of physical, psychological, social and spiritual 
component of a human being which has been given in Thirumanthiram as 
“One that cures physical ailment is medicine 
  One that cures psychological ailment is medicine 
  One that prevents ailment is medicine and  
  One that prevents immortality is medicine” 
        -Thirumoolar 
As per siddha system physical health of human body is maintained by the 
three basic vital humours namely: 
1. Vatham 
2. Pitham 
3. Kabam 
They are called as uyirthathukal when these vital humours get vitiated by the 
life style modifications and then they are called as kutrams and that leads to the 
diseases.  
In siddha system of medicine the disease of human beings are classified into 
4448 types on the basics of Mukkutram theory. The word Haemorrhoids is derived 
from Greek word ‘Haimorrhoidesphlebes’ which means ‘Bleeding veins’. 
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In Siddha system of Medicine Bleeding Piles may be compared with 
RatthaMoolam. Sage Yugi classified Moola Noi into 21 types. Bleeding Piles is one 
among them.  
Now- a- days people neglect symptoms like constipation, which later on may  
produce, Haemorrhoids, prolapse and fissure-in-ano.
 
 
In India, the Prevalence is 4.2–7.9% and approximately 40,723,288 people are 
reported to have hemorrhoids.
[2]
 One million new cases are reported annually. 
Currentstatistics suggest nearly half of the world’s population experiences some form 
of hemorrhoids especially when they reach the golden age of fifty. 
 Moola noi (Haemorrhoids) is one among the 4448 diseases. Rattha moolam is 
one among the 21 types of Moola noi which is mentioned in Yugi vaithiya 
chinthamani. Rattha moolam is compared with 1
st
 degree internal haemorrhoids in 
modern aspect. 
 Increased risk of being overweight, pregnancy, aging, lifestyle modification, 
lack of physical activities, sedentary occupation heredity and food habits are the 
factors of Hemorrhoids. People above 50 years of age are commonly affected. 
In our Siddha system, Siddhars tells us plenty of drugs and preventive 
measures. In that, I took one of the medicines, MOOLAROGA CHOORANAM stated 
by Pulipani, in the text book “PULIPANI VAITHIYAM 500” 
In Ratthamoolam cardinal complaint is bleeding per rectum. Bleeding or 
Haemorrhage is one such condition, which has to be treated promptly with utmost 
care, and requires a pragmatic approach. Any failure to treat unbridled bleeding can 
lead to dangerous and often fatal consequences. The Siddha medicines have immense 
potential to cure diseases with minimal or no adverse effects. In this way, peoples 
with Bleeding haemorrhoids can be cured without adverse reactions through Siddha 
drug. So, I preferred to select Ratthamoolam as my dissertation topic.  
The drug Moolaroga Chooranam, indicates that it cures all types of Moola 
Noi. I hope this drug will definitely help to cure the RATTHA MOOLAM 
[BLEEDING PILES]. 
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AIM AND OBJECTIVES 
AIM: 
 The purpose of this study is to evaluate the safety and efficacy of Siddha 
herbal formulation "MOOLAROGA CHOORANAM" in the treatment of Rattha 
Moolam. 
OBJECTIVES: 
 Collection of various Siddha literatures of the study. 
 Herbal identification and authentication of the trial drug. 
 To prepare the trial drug "MOOLAROGA CHOORANAM" as per Standard 
operating procedure drug preparation.  
 To study the evaluation of Siddha trial drug “MOOLAROGA 
CHOORANAM” for Rathamoolam. 
 To evaluate the Biochemical, Physico-chemical analysis of the trial drug. 
 To evaluate the safety profile like Acute toxicity , Sub acute toxicity of the 
trial drug in animal models as per OECD guidelines  
 To correlate the Siddha aspects of Rathamoolam to Bleeding piles of modern 
medicine with respect to causes, pathology, and clinical features. 
 To gather the Siddha diagnostic parameters by Mukutram, Udal thathukkal, 
Uyir thathukkal  and En vakai thervugal. 
 To use modern parameters to confirm the disease. 
 To make a clinical observation about the disease in relation of age, sex, 
occupation, Socio-economic status. 
 To subject all patients are to thorough investigation before and after 
treatment. 
 To find out the statistical analysis and efficacy of the drug through clinical 
study. 
 
  
 
 
Review of  
literature 
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REVIEW   OF   LITERATURE 
SIDDHA ASPECT 
In Siddha literature view they are 4,448 disease, classified by our Siddhars. 
Moolam is one of the disease.  In Yugi munivar apepect he says twenty one types of 
Moola Noi, in text book of Yugi Vaidhiya Chinthamani. RATTHAA MOOLAM is 
one among them. According to Siddhar therayar 
In siddha aspect disease are diagnosed on basis of mukkuttram, In Moola Noi, 
Vadham and Pittham kuttrams are elevated. 
   
RATTHAA MOOLAM 
IYAL [DEFINITION] 
            Ratthaamoolam is a disease characterized by inflammation on one are more 
veins [Kaar kuruthi kuzhal] of sigmoid colon to rectum. It produces burning 
sensation, itching in the anus   Bulging of veins during constipation, so that difficult 
to passing stools, rupture the veins and produce blood with stools. 
VERU PEYAR [SYNONYM] 
                   Kuruthi moolam 
NOI VARUM VALI 
 
According to Yugi Vaithiya Chinthamani, the causes of Moola Noi are, 
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[3] 
- 
 
 Due to heat                                         
 Due to sexual extravagance 
 Due to spicy & sour foods 
 Due to selfishness & angry 
 Due to mental illness 
According to Thirumoolar Karukkidai Vaithiyam, 
[4]
 
-  
 Loss of appetite 
 Fasting 
 Constipation 
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According to Agathiyar paripooranam400  Moola Noi occurs due to old Sins . 
[5]
 
-  
 
MURKURIGUNANGAL [SIGNS] 
 Loss of appetite 
 Indigestion 
 Thirst sensation 
 Weakness 
 Anger 
 Constipation 
NOI ENN[TYPES] 
According to Yugi muni, 
SIDDHA ASPECT 
 
A Study On Ratthaamoolam With The Evaluation Of Siddha Drug Moolaroga Chooranam Page 7 
 
[6]
 
- 
 
1. Chendu moolam          
2. Mulai moolam             
3. Varal moolam              
4. Ratthaa moolam         
5. Seezh moolam               
6. Neer moolam                  
7. Aazhli moolam   
8. Thamaraga moolam  
9. Vali moolam      
10. Azhal moolam    
11. Aiya moolam     
12. Thontha moolam   
13. Vinai moolam 
14. Mega moolam         
15. Pavuthira moolam  
16. Kirathi moolam 
17. Siru moolam             
18. Kutha moolam    
19. Pura moolam   
20. Churukku moolam     
21. Chavvu moolam                                                                                                   
  Among the 21 types, 9 types are incurable & other 12 types are curable, 
Raththamoolam is a curable Moola Noi. 
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THEERUM [CURABLE] 
1. Neer moolam                       
2. Peru   moolam                      
3. Varal moolam                      
4. Vali moolam                         
5. Azhal moolam      
6. Mega moolam   
7. Kuzhli moolam      
8. Kuruthi moolam       
9. Pura moolam           
10. Chavvu moolam 
11. Churukku moolam 
12. Kiranthi moolam 
Moola Noi is classified by various type of authors, Some of the types are below. 
In the text of Agathiyar paripooranam 400, Agathiyar describes 9 types of Moola 
Noi. 
1. Ul moolam                           
2. Pura moolam                       
3. Ratthaa moolam                    
4. Seezh moolam 
5. Mulai moolam      
6. Moola paandu   
7. Vali moolam   
8. Azhal moolam    
9. Aiya moolam                                 
In Agathiyar 2000, Moola Noi is classified into 10 types. 
1. Ul moolam                                        
2. Pura moolam                                     
3. Vaadha kiraani                                   
4. Pittha kiraani                                      
5. Sileththuma moolam  
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6. Vadha piththa moolam   
7. Pittha sileththuma moolam  
8. Vatha siltthuma moolam   
9. Kadukku moolam                    
10. Sivappu moolam [Ratthaa moolam] 
POTHU KURIKUNAGAL [SYMPTOMS] 
According to Yugi Vaithiya Chinthamani, the symptoms are 
- 
 Pain around the umbilicus 
 Bleeding during defecation 
 Anaemia 
 Pain in the limbs 
 Giddiness 
According to text book of Aathmaratchamirtham,
  
 
 
SIDDHA ASPECT 
 
A Study On Ratthaamoolam With The Evaluation Of Siddha Drug Moolaroga Chooranam Page 10 
 
 Pain in the umbilicus 
 Constipation 
 Enhance bitter & sour 
 Loss of appetite 
 Anaemia 
[7]
   
 
 Anaemia 
 Excess of gas in the abdomen 
 Loss of appetite 
 Enhance bitter & sour 
According to Thirumoolar Karukkidai Vaithiyam, 
[8]
 
 
According to  Agathiyar Guna Vagadam Nool
 [9]
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[9] 
  
 
 Bleeding per  rectum through rectal vein 
 Curable disease by treatment 
 Bleeding for longer duration causes headache. 
According to Thanvanthiri Vaithiyam
[10]
 
  
 
 Pain in the umbilicus 
 Bleeding per rectum 
 Protrusion of pile mass 
According to Agathiyar Aayulvedham 1200 
 
[11] 
 Burning sensation in the anus 
 Constipation 
 Bleeding per rectum 
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According to Theran Segarappa, 
[12] 
 
 Hard consistency & white coloured faeces 
 Constipation 
 Bleeding per rectum 
MUKKUTRA VERUBADU 
Keelvaai kanal increased, due to the food habits. So it stimulates the 
vadha and pitha kuttram. 
                “ 
NAADI  
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THINAI 
Geographically, the living country has been divided into five distinct physical  
regions, namely:- 
 Kurunchi – Hilly regions 
 Mullai     - Forest regions 
 Marutham – Fertile regions 
 Neithal   - Sea regions 
 Palai – Sandy regions 
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            Each regions has got its own characteristic features which influence the 
inhabitants, mental, physical, economic, occupational and cultural activities. In each 
regions on basis of its peculiar physical and climatic features some ailments are 
endemic. The preventive and curative measures for these ailments are stated in the 
medical literature. 
KALAM (Seasons) 
  With reference to the position of the sun in the orbit, the year is 
divided into six seasons. They are,  
 Kaar kalam – Aavani and Purattasi  ( August 17  to October 16) 
 Koothir kalam – Ippasi and Karthigai (October 17 to December 15) 
 Munpani kalam – Markazhi and Thai(December 16 (2016) to February 12 
(2017) 
 Pinpani kalam – Maasi and Panguni (February 13 to April 13, 2017  ) 
 Elavenin kalam – Chithirai and Vaigasi (April 14 to June 14 ) 
 Muduvenir kalam – Aani and Aadi (June 15 to August 16) 
In every season there will be some changes in the land, water, plants, animals, 
and human beings, which will modify the physiology and rendering them more 
susceptible to certain specific disease which are common in these seasons. 
The Siddhars had good knowledge about those changes and advised certain 
measures in the form of diet, purgative exercises, etc, to avoid the onset of such 
ailment.
[13]
 
UYIR THATHU: 
 Knowledge of three Uyir thathus and seven Udal kattugal will be helpful to do 
detailed study on the disease. 
VATHAM: 
The term vatham denotes vayu, dryness, pain and flatulence.  
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Location of Vatham: 
 Vatham located in the abanan, face, idakalai, spermatic cord, pelvic bone, 
skin, nerves, joints, hairs and muscles. It’s mathirai is 1. 
TYPES OF VATHAM:  
It is divided into 10 types; 
1. PRANAN  ( Uyir Kaal ) 
      It is responsible for respiration and digestion. In Ratthaa moolam some patients 
affected respiratory illness due to anaemic. 
2. ABANAN  ( Keezhnokku Kaal ) 
         It lies below the umbilicus responsible for the downward expulsion of stools, 
urine and constriction of anal sphinchters. In Ratthaa moolam  many patients having 
constipation, itching and burning sensation in anus,bleeding per rectum, some 
patiohaving pile mass due to defect of this vaayu. 
3.VIYANAN ( Paravu Kaal )  
        It is responsible for Nourishment of whole body. 
4.UTHANAN  ( Melnokku Kaal ) 
It is responsible for Speech, expelling vomitus, hic-cough 
5.SAMANAN  ( Nadu Kaal ) 
It is responsible for the balancing of the vayus: absorption of nutrient’s and 
balance of the body. In Ratthaa moolam some patients are affected. 
 6.NAGAN: 
     It is responsible for the movement for eyelids. 
7.KOORMAN: 
    It is responsible for the sight, closing of eyelids, yawning and closure of 
mouth. 
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8.KIRUKARAN: 
    It is responsible for the secretion of mouth and nose, appetite, sneezing, cough. 
In Ratthaa moolam some of patients affected loss of appetite. 
9.DEVATHATHAN: 
    It is responsible for aggravating of the emotional disturbances anger, etc.In 
Ratthaa moolam some patients are affected due to Insomnia. 
10. THANAJAYAN: 
    It escapes from the head on the third day after death.
[14] 
TYPES OF PITHAM 
 It is the thermal life force of the body.  It’s   mathirai ½. 
Location Of Pitham: 
Pitham is located  in Pirana Vayu, blood , moolakini,  heart, umbilical region, 
abdomen, sweating, saliva, eyes and skin. 
Functions Of Pitham: 
 Pitham controls digestion, temperature, vision, appetite, thirst, taste and 
strength of the body. It is responsible for the formation of red or yellow colour in the 
body and heat especially during digestion. It is also responsible for giddiness, increase 
of blood, discolouration of stools, urine, anger, memory and bitter and sour taste. 
TYPES OF PITHAM 
1. ANALA PITHAM 
This is responsible for digestion of food. It located in stomach and intestine. In 
Ratthaa moolam some patients are affected. 
 
2. RANJAGA PITHAM 
It is responsible for the colour and contents of blood. In Ratthaa moolam patients 
are affect in anaemia due to bleeding while daefecation. 
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3. SAATHAGAM :  
It   lies in the heart. It is responsible for the action after thinking.In Ratthaa 
moolam all patients are affected. 
4. PRASAGAM: 
It is responsible for the complexion of skin. In Ratthaa moolam patient having 
pale skin due to anaemic. 
5. AALOSAGAM 
It is responsible for the vision.
[15]
 
KABAM: 
It is responsible for the stream line functions of the body and maintains body’s 
defence mechanism intact. It is mathirai ¼. 
Location Of Kabam:             
Kapham is located in samana vayu, sperm, head, tongue, uvula, fat, bone 
marrow, blood, nose, chest, nerve, bone, brain, eyes, and joint and it provides the 
material for the structure of every cell of the body. 
Functions Of Kabam: 
        Generally it acts as a distructive factor in the body. When Kaphem is in 
normal condition, it maintains heart function, taste, coolness of eyes, lubricates and 
aids free movements of the joints. 
TYPES OF KABAM 
1. AVALAMBAGAM 
It causes diseases of the respiratory system when it is affected thereby indirectly 
affecting the other Iyyams. 
 
2. KILETHAGAM 
  Appetite and digestion may not be normal when it is affected. In Ratthaa 
moolam some patients affected due to loss of appetite. 
 
3. POTHAGAM 
It is present in the tongue and gives and taste. 
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4. THARPAGAM 
Memory and perception of sense may be affected when this is deranged. 
 
5. SATHIGAM 
   It is present in the joints and helps free movements. Some patients have mobility 
of joints is affected due to drying up of the synovial fluid.
[16] 
SEVEN UDAL THATHUKKAL: 
There are seven primary body tissues which constitute the entire human body 
and all the organs of the various system. 
1. SAARAM: 
Saaram the end product of digestive process. It provides strength to the body and 
mind.  
2. SENEER: 
The saram after absorption is converted into seneer. It is provides for knowledge, 
strength and health complexion. In Ratthaa moolam  patients have anaemia due to 
blood loss. 
3. OON: 
It gives figure and shape to the body. It is responsible for the movement of the 
body. 
4. KOZHUPPU: 
It provides lubrication to organs and thus facilitates their function. 
5. ENBU: 
Gives shape to the body, helps locomotion and protects vital organs. 
6. MOOLAI ( MACHAI ) 
Present in the bone and it gives strength, maintains the normal condition of the 
bone. 
7. SUKKILAM OR ( SURONITHAM ) 
 Responsible for reproduction.[17] 
PINIYARI MURAIMAI: 
 The method adopted to find out a disease in Siddha is known as  
Piniyari muraimai.  
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It is based on the following principles. 
 
 Poriyal Arithal 
 Pulanal Arithal 
 Vinavuthal 
“Pori” is the five organs of perception namely, 
 Nose 
 Eyes  
 Tongue  
 Ears 
 Skin.  
“Pulan” are the actions using Pori. They are Sense, Smell, Taste, Vision, and 
Auditory respectively. 
Poriyalarithal and Pulanal Arithal, go hand in hand with the concept to 
examine the patients “ Pori “ and “ Pulan“ with that of the “ Patients” Pori and 
Physician “Pulan”. 
“Vinavuthal” is a method of inquiring the detail of either the patients problem 
that made him to approach the physician from his own or his / her attendents who 
accompany them. 
    Along with, above mentioned principles is also carried out inspection in 
modern medicine. Besides, Thottuparthal ( palpation ) and Thattiparthal ( percussion ) 
are also used to diagnose a patient. 
 The primi method adopted to diagnose the disease is by means of “ Envagai 
Thervugal “ ( Elight types of investigation ), Envagai Thervugal of Physician 
instruments and can be understood by the following versus. 
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Eight fold system of clinical assessments: 
 Siddhars have given eight diagnostic methodological tools. They are 
1. Naadi 
2. Sparisam 
3. Naa 
4. Niram 
5. Mozhi 
6. Vizhi 
7. Malam 
8. Moothiram 
In Ratthaa moolam Naa, and vizhi keel affected due to anaemia, Malam 
affected due to constipation. 
SPARISAM: 
 By sparisam, the temperature of skin (thatpam- cold or veppam – heat), 
smoothness, roughness, sweating, dryness, hard patches, swelling, abnormal growth 
of organs and tenderness can be felt. 
 In Ratthaa moolam sparisam not affected. 
 
NAA: 
 Signs and symptoms in the tongue are noted here. Colour salivary secretion, 
ulcers, coating, inflammation, taste changes, deviation and its nature are generally 
noted. 
 In Ratthaa moolam, the naa is affected due to anaemia. 
 
NIRAM: 
 The colour of the skin is noted here. 
 In Ratthaa moolam,, Niram is affected, in case of  severe anaemia. 
 
MOZHI: 
 Character of the speech is noted, mainly uraththa oli (high pitched), thazhndha 
oli (low pitched), or resembles the sound of any instrument. 
 In Ratthaa moolam, mozhi is not affected. 
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VIZHI: 
 Character of the eye is noted. Colour, warm, burning sensation, irritation, 
visual perception are generally noted. 
 
MALAM: 
 The stools are examined for quantity, hardening (malakattu), loose motion 
(bedhi), colour and smell. 
 In Ratthaa moolam, Malam was affected in all patients due to constipation. 
 
MOOTHIRAM 
 
NEERKURI (Urine examination)  
 Urine examination is good diagnosis method compare to naadi and 
Envagai thervugal. Theraiyar mention below as. 
 
 
     
 Noi Nadal Noi Muthal Nadal Thirattu  
The early morning urine sample is collected and sample should be examined within 
one and half hours. 
 
SIRUNEERIN POTHU GUNAM: 
  “
 
 Noi Nadal  Noi Muthal Nadal Thirattu 
 
The urine is examined for its Niram (colour), Eadai (Specific gravity), Nurai 
(Froth), Natram (Smell), Enjal (Deposits). 
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NIRA THOGAI 
  “
[18]
 Noi Nadal Noi Muthal Nadal Thirattu 
1. Yellow 
2. Red 
3. Green 
4. Black 
5. White  
Urine may be any colour mentioned above. 
 
EADAI (SPECIFIC GRAVITY) 
  
  “
 Noi Nadal Noi Muthal Nadal Thirattu 
 
NAATRAM (SMELL) 
  
  “
[19]
  ……………………………………… 
 Noi Nadal Noi Muthal Nadal Thirattu 
NURAI (FROTH) 
  
  “
[20]
 Noi Nadal Noi Muthal Nadal Thirattu 
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ENJAL (DEPOSITS) 
 
[21]
 Noi Nadal Noi Muthal Nadal Thirattu 
 In Ratthaa moolam, There are no abnormal changes present in Neerkuri. 
 
NEIKURI 
 The early morning urine of the patient is analyzed by dropping a drop of 
gingely oil on the surface of the urine sample. The accumulation, formations, changes, 
and dispersal under the sunlight without any external disturbances of the urine sample 
can be noted. 
The urine kept on the kidney tray in sun light, on non wind condition, should 
be examined by dropping a drop of gingili oil gently with rod. If oil spread like snake, 
it indicates valineer, a ring indicates azhal neer and float like a pearl indicates iyya 
neer and sinks in urine indicates mukkutram.
  
 
[22]
 Noi Nadal Noi Muthal Nadal Thirattu 
 
 Vatha neer – The oil spreads like snake 
 Pitha neer – The oil spreads like ring 
 Kabha neer – The oil spreads like pearl 
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 If the oil spreads gradually, it indicates good prognosis 
 If the oil spreads fast or gets mixed completely with urine or sinks 
in urine, it suggests bad prognosis. 
 
Ratthaa moolam, is due to derangement of vatham and pitham,  
The Neikuri is pitha neer or vatha neer. 
LINE OF TREATMENT 
Purgatives are given as initial measures. 
                    In Moola Noi, vadham  is affected, So purgatives are administered on 
the previous day of medicine. 
 Then administration of internal medicine. 
 Avoid long duration of sitting 
 Avoid spicy food 
DIET REGIMEN FOR MOOLA NOI 
 Karunai kilangu 
 Vilangu meen 
 Thuthi keerai 
 Thaali keerai 
 Pasalai keerai 
 Vendhaya keerai 
 Karunaikizhangu 
 Saenaikizhangu 
 Vendaikkai 
 Atthikkai 
 Kovaikkai  
 Green vegetables 
 Pork 
 Snail  
 Butter milk 
 Butter 
 Ghee 
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 Fiber content food  
 Oat bran, Rice bran 
 Fruits. 
 Drink plenty of water. 
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MODERN ASPECT 
ANATOMY OF THE RECTUM 
 
DEFINITION: 
The rectum is the distal part of the large gut. It is placed between the sigmoid 
colon and anal canal. Distention of the rectum causes the desire to defaecate. 
SITUATION 
        The rectum is situated in posterior part of the lesser pelvis, In front of the 
lower three pieces of the sacrum and coccyx. 
 DISTRIBUTION 
   The rectum is 12 cm in length, and it is Intraperitoneal at its proximal and 
anterior end, and is extra peritoneal at its distal and posterior end. The epithelial lining 
or mucosa of the rectum is of a simple columnar mucous secreting variety.
[23] 
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PHYSIOLOGY  
FUNCTIONAL PART OF RECTUM 
Rectum has two functional parts. The upper part related to hindgut lies aboue 
middle fold of the rectum.It acts as a faecal reservoir which can freely distend 
anteriorly. The lower part of peritoneum lies below the middle fold it is empty in 
normal individuals, But may contain faeces in case of chronic constipation. 
DAEFECATION REFLEX
 
            The mass movements drive the faeces in to the sigmoid or pelvic colon.in the 
sigmoid colon the faeces is stored.The desire of daefecation when some of faeces 
enters rectum due to the mass movements.The desire of daefecation is elicited by an 
increase in the intrarectal pressure to about 20 to 25cm H20.The process of 
daefecation the contraction of the rectum and relaxation of the internal and external 
anal sphincter.
[24] 
ANATOMY OF ANAL CANAL 
DEFINITION 
                  The Anal canal is the terminal part of the large intestine. 
SITUATION 
          It lies in the anal triangle of peritoneum inbetween the the right and left 
ischiorectal fossae. 
DISTRIBUTION 
            The anal canal is 3.8cm long.It extent from the ano-rectal junction to the anus. 
The dentate line is a imaginary line near the midpoint of the anal canal. This location 
lies, where the anal crypts are found. 
ANORECTAL RING 
             This is a muscular ring present in the ano-rectal junction. It is formed by the 
pubo rectalis, deep external sphincter and internal sphincter.It is easily felt by a finger 
in the anal canal.
[25] 
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PHYSIOLOGY OF THE ANAL CANAL
 
The proximal end of the anal canal is the point at which the columnar 
epithelium of the rectum becomes a transitional epithelium. This epithelium 
transitions to a stratified squamous variety at the dentate line. The distal most end of 
the anal canal is the anal verge which is the point where the stratified squamous 
epithelium becomes true skin marked by the presence of hair follicles and sweat 
glands.  Anal glands secrete mucus that empty into the anal crypts by way of anal 
ducts. 
BLOOD SUPPLY 
The blood supply to the anorectal region is rich. The terminal branch of the 
inferior mesenteric artery is the superior hemorrhoidal (rectal) artery. The superior 
hemorrhoidal artery branches into right and left branches; the right branch further 
divides into anterior and posterior branches. The classic hemorrhoidal plexes are then 
located at the left later, right anterolateral, and right posterolateral locations. The 
middle hemorrhoidal (rectal) arteries are direct branches from the internal iliac 
arteries. The inferior hemorrhoidal (rectal) arteries are branches off the pudendal 
arteries which also arise from the internal iliac arteries. 
The superior, middle, and inferior hemorrhoidal arteries complete the rich 
arterial supply to the anorectal region. 
VENOUS DRINAGE 
                 The venous drainage of the anorectal region consists of superior 
hemorrhoidal veins draining into the portal venous system (by way of the inferior 
mesenteric vein) and the middle and inferior hemorrhoidal veins draining into the 
caval system (by way of the internal iliac veins) 
NERVE SUPPLY 
               The rectum is supplied by sympathetic[L1,L2] Parasympathetic[S2,S3,S4] 
Superior rectal and inferior hypogastric plexuses.Pain sensation are carried by both of 
them.
[26]
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   HAEMORRHOIDS  
 
In greek-Haima = blood, Rhoos = flowing   Syn. Piles in Latin-Pila = ball
 
Varicosities of the anal canal are known as haemorrhoids. It may be internal or 
external depending upon the position of the varicosity. If it is above the Hilton’s line 
it is called ‘internal haemorrhoid’ and if it is below the Hilton’s line it is called 
‘external haemorrhoids’. So internal haemorrhoid is covered with mucus membrane 
and external haemorrhoid is covered with skin.
[27] 
The veins which form internal haemorriods become engorged as anal lining 
descends and is gripped by the anal spincters. The two varieties may coexist and the 
condition is called intero-external Haemorrhoids. 
Dilatation of the vein at the anal verge is sometimes seen in persons of 
secondary life particularly during staining. Peri anal hematoma or thrombosed 
external haemorroid-A small in the peri anal subcutaneous tissue can be seen 
superficial to ani muscle. This condition is due to back pressure on the anal venule 
consequent upon straining a stool, coughing or lifting  heavy weight.
 
AETIOLOGY: 
                     Hereditary    - It often seen in members of the same family due to 
weakness of vein walls since birth.
 
                 Morphological -. In quadrupeds, gravity aid or at any rate does not retard, 
                                               return of venous  blood from the rectum. 
                 Anatomical      - Absence of venous valves and lack of muscular or fascial 
support of the hemorrhoidal plexus. 
 Extreme looseness of the submucus connective tissue rendering the effect of 
gravity particularly harmful in thesitting and standing postures. 
 The passage of the tributaries of the superior hemorrhoidal vein directly 
through muscular wall of the rectum abouth 7 ½ cm above the anus causing 
intermittent constriction of the veins at the point. 
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 The plexiform anastamoses just within the anus between inferior and middle 
and the superior hemorrhoidal tributaries so that the former, although connected with 
the systemic circulation, are subject to dilatation as result of portal junction. 
The communication of superior haemorrhoidal vein with the inferior 
mesenteric vein and thus with portal system, which is subject to periodic physiologic 
congestion and to frequent pathologic obstructions. 
 The relation of the inferior hemorrhoidal veins and of the terminal branches of 
the inferior mesenteric veins to the fecal contents of the sigmoid and rectum, exposing 
them to frequent pressure. 
             Excisting causes – Once dilatation of the venous plexusbas well as partial 
prolapsed would  occur with each bowel movement it would stretch  the mucosal 
suspensory ligament.  
            Diet                    - Low roughage ‘western’ diet, consuming spicy foods etc. 
 
PATHOLOGY:  
Through Protoscopy the internal hemorrhoids are well visualized and can be 
divided in to three parts, 
Pedicle – Lie just above the anorectal ring, covered with pale pink mucosa and 
through superior rectal vein can be seen. 
Body of internal haemorriod – After the pedicle, it distally ends at the dentate 
line. It is covered by red or purple mucous membrane. 
Associate external Haemorroid – It lies between the dentate line and the anal 
margin and it is covered by skin. Each primary internal haemorroid contains main 
three terminal divisions of superior rectal artery & vein, In lithotomy position it’s left 
lateral [3’Oclock] right lateral [7’Oclock] right posterior[11’Oclock][28] 
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CLINICAL FEATURES: 
BLEEDING 
It  is the earlist symptom of haemorrhoids. It is bright red in colour, painless 
and occurs during daefecation [a splash in pan].It may continuously or intermittently 
thus for months or years. In this condition that bleeds but does not prolapsed outside 
the anal region. 
PROLAPSE 
It is a lateral symptom. According to prolapsed Hemorrhoids can be divided 
into four types. 
FIRST DEGREE 
First degree haemorrhoids are those in which hypertrophy of the internal 
haemorrhoidal plexus remains entirely within the anal canal as the mucosal 
suspensory ligaments remain intact. Patients in this stage usually present with Rectal 
bleeding and discomfort or irritation. Bleeding is bright red and occurs during 
daefecation as Splash in the pan. It may continue for months or years. 
SECOND DEGREE 
Haemorrhoids occur when with further hypertrophy, the mucosal suspensory 
ligaments become lax and piles will descend, so that they prolapsed during 
daefecation. But spontaneous reduction takes place afterwards. There may be a small 
skin tag. Some mucosal discharge, soreness and irritation. 
THIRD DEGREE 
Haemorrhoids, they remain prolapsed after daefecation and require 
replacement. This often descends spontaneously or on exercise. The mucosas 
overlaying such haemorrhoids undergo squamous metaplasia. Mucosal discharge and 
pruritis ani become troublesome and anaemia become obvious, secondary 
haemorrhoids occur between the three primary ones, the most common being the mid 
posterior portion. There may be a large skin tag.
[27] 
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FOURTH DEGREE 
The Haemorrhoids that are permanently prolapsed. 
 
 
 
 
PAIN 
It is not characteristic of Haemorroid unless there is associated thrombosis or 
fissure in ano. 
MUCOUS DISCHARGE 
It is a particular symptom of prolapsed Haemorrhoids. 
ANAEMIA  
Is often seen in long standing causes of Haemorrhoids. 
 
DIAGNOSIS 
In the begining with a physical examination to find out any swollen veins that 
may be causing external hemorrhoids. During this physical examination. Procedures 
such as a colonoscopy, anoscopy, sigmoidoscopy, or proctoscopy will used any 
possible abnormalities. In case of internal hemorrhoids, an endoscopy is used to 
examine inside the anus. 
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DIFFERENTIAL DIAGNOSIS 
 Anal fissure 
 Ano-rectal abscess 
 Fistula 
 Rectal prolapsed 
 Pruritis 
 Rectal polyps [29] 
COMPLICATIONS: 
 Thrombosis 
 Fissure in ano 
 Pyelophlebitis 
 Fibrosis[30] 
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TRIAL DRUG REVIEW 
Drug Name:  Moolaroga chooranam 
Reference: Pulipani vaithiyam 500 
 
Preparation: 
[31] 
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INGREDIENTS: 
ROOTS OF THE FOLLOWING PLANTS: 
 Thoothuvalai   (Solanum trilobatum) 
 Marul kizhangu  (Sansevieria roxburghiana) 
 Karunai kizhangu  (Amorphophallus paeoniifolius) 
 Pirandai   (Cissus quadrangularis) 
 Nilavaarai (Cassia senna) 
 Kaatu karunai  (Amorphophallus sylvatus) 
 Arugan kattai  (Cynodon dactylon) 
 Neermulli   ( Hygrophila auriculata) 
 Milagaranai  (Toddalia asiatica) 
All the ingredients are taken in equal ratio. 
All the ingredients are purified, powdered and stored in an air tight container. 
 
REFERENCE : PULIPPAANI VAITHIYAM 500 
DOSE   : 1 Gram,  Twice a day 
ADJUVANT  : Honey 
DURATION  : 48 Days 
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PROPERTIES OF TRIAL DRUGS: 
1. THOOTHUVALAI 
 
Botanical name : Solanum trilobatum 
Family  : Solanaceae 
Taste   : Bitter, Pungent 
Thanmai  : Veppam 
Pirivu   : Kaarppu 
 
Phytochemicals: 
 Sobatum 
 Β- solamarine 
 Solasodine 
 Solaine 
 Glycol alkaloid 
 Diosogenin 
 Saponin 
 Tannin[32] 
 
Action : 
 Stimulant  
 Anti inflammatory 
 Expectorant 
 Tonic 
 
Gunam: 
 “
[33] 
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2. MARUL KIZHANGU 
 
Botanical name : Sansevieria roxburghiana 
Family  : Liliaceae 
Taste   : Pungent, Sweet 
Thanmai  : Veppam 
Pirivu   : Kaarppu 
 
Phytochemicals: 
 Sansivierine 
 Palmitic acid 
 Phthalate 
 Delta undecalactone 
 N- hexadecanoic acid 
 Pentadecanone 
 Methyl hexadecanoate[34] 
 
Action: 
 Purgative 
 Tonic 
 Stimulant 
 
Gunam: 
 
[35]
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3. KARUNAI KIZHANGU 
 
Botanical name : Amorphophallus Paeonifolius 
Family  : Araceae 
Taste   : Pungent 
Thanmai  : Veppam 
Pirivu   : Kaarppu 
 
Phytochemicals: 
 Alkaloids 
 Flavanoids  
 Fats 
 Fixed oils 
 Tannins 
 Phenols 
 Carbohydrates 
 Proteins and amino acids 
 Sterol 
 Terpenoid [36] 
 
Action: 
 Stimulant 
 Astringent 
 Gunam: 
[37]
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4. PIRANDAI 
 
Botanical name : Cissus quadrangularis 
Family  : Vitaceae 
Taste   : Pungent 
Thanmai  : Veppam 
Pirivu   : Kaarppu 
 
Phytochemicals: 
 Quarcetin 
 Quadrangularin 
 α and β amyrins 
 Kaempferol 
 Resveratrol 
 Pallidol 
 Piceatanon 
 Perthinocissi 
 Carotene 
 Vitamin C[38] 
 
Action: 
 Alterative 
 Emmenagogue 
 Stomachic 
Gunam: 
[39]
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5. NILAVAARAI 
 
Botanical name : Cassia sennna 
Family  : Cesalpinoideae 
Taste   : Bitter 
Thanmai  : Veppam 
Pirivu   : Kaarppu 
 
Phytochemicals: 
 Sennaside A 
 Sennaside B[40] 
 
Action: 
 Purgative 
 Laxative 
Gunam: 
[41] 
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6. KAATTU KARUNAI 
 
Botanical name : Amorphophallus sylvatus 
Family  : Araceae 
Taste   : Bitter 
Thanmai  : Veppam 
Pirivu   : Kaarppu 
 
Action: 
 Stomachic 
 Rubefacient 
 
Phytochemicals: 
 Alkaloids 
 Tannins 
 Steroids  
 Flavanoids 
 Glycosides 
 Volatile oil 
 Sterol 
 Flavanoids 
 Saponins 
 Phenol compound[42]  
 
Gunam 
[43]
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7. ARUGANKATTAI 
 
Botanical name : Cynodon dactylon 
Family  : Poaceae 
Taste   : Sweet 
Thanmai  : Thatpam 
Pirivu   : Inippu 
 
Chemical constituents: 
 Linolenic acid 
 Hexadecanoic acid 
 Benzofuran 
 Levoglucosenone 
 Cinnamic acid 
 Tumerone 
 Vanillic acid 
 Syringic acid 
 Hexanediamide 
 Pantolactone [44] 
 
Action: 
 Styptic 
 Astringent 
 Emolient 
 Diuretic 
Gunam: 
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8. NEERMULLI 
 
Botanical name : Hygrophila  auriculata 
Family  : Acanthaceae 
Taste   : Sweet, Light bitter 
Thanmai  : Thatpam 
Pirivu   : Inippu 
 
Chemical constituents: 
 Asteracanthine 
 Asteracanthicine 
 Hentricontyle acetate 
 Stigmasterol 
 Lupeol 
 Hentricotane 
 Betulin 
 Luteolin 
 Glucuronide 
 Apigenin[46] 
 
Action: 
 Refrigerant 
 Diuretic 
 Demulcent 
 
Gunam: 
[47] 
-  
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9. MILAGARANAI 
 
Botanical name : Toddalia asiatica 
Family  : Rutaceae 
Taste   : Astringent 
Thanmai  : Thatpam 
Pirivu   : Kaarppu 
 
Chemical constituents: 
 Toddalenol 
 Toddalosin 
 Toddalenone 
 Oxyavicine 
 Bergapten 
 Luvangetin 
 Diosmin 
 Diosmetin 
 Norbraylin 
 Robustine 
 Dictamine[48] 
Action: 
 Stimulant 
 Tonic 
 Diaphoretic 
 Antiperiodic 
Gunam: 
[49]
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INGREDIENTS OF TRIAL DRUG 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thuthuvalai ver 
Pirandai ver 
Nilavarai ver 
Thoothuvalai plant 
Pirandai 
Nilavarai 
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Marul 
Milagaranai ver 
Arugan kattai 
Neermulli plant Neermulli root 
Milagaranai plant 
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   MATERIALS & METHODS 
STUDY DESIGN: 
         A clinical trial on RATTHA MOOLAM was conducted at the OPD section of  
POST GRADUATE, POTHU MARUTHUVAM DEPARTMENT attached to 
ARIGNAR ANNA HOSPITAL OF INDIAN MEDICINE, Chennai-106, during the 
period 2015- 2017. 
A Study was approved by Institutional Ethics Committee(IEC) and the 
approval number is GSMC-CH-ME-4/2015/002. The study was registered in Clinical 
trials Registry,India (CTRI) and the CTRI number is CTRI/2017/05/008568. 
POPULATION AND SAMPLE: 
           The sample consists of all patients satisfying the inclusion and exclusion 
criteria mentioned below. Population consists of Rattha moolam patients attending the 
OPD of Arignar Anna Hospital, Arumbakkam, Chennai-106. 
SAMPLE SIZE: 
         The trial size was 40 patients. 
INCLUSION CRITERIA: 
 Age 20  to 60 years 
 Patients with appropriate symptoms like,  bleeding during  
defecation, Constipation, 
 Loss of appetite  
 Giddiness, tiredness 
 Patients who are all willing to give blood samples at subsequent 
visit are involved in this study. 
EXCLUSION CRITERIA (CLINICAL HISTORY): 
 Pregnant and lactating women 
 External haemorrhoids 
 Fissure in ano 
 Second degree haemorrhoids 
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 Fistula 
 Hypertension 
 Diabetes mellitus 
 CA Rectum 
WITHDRAWAL CRITERIA: 
 Intolerance to the drug and development of any serious adverse 
effects during the  trial (If ADR is reported the patient was to 
be directed to RPC) 
 Patients turned unwilling to continue in the course of clinical 
trial 
 Poor compliance. 
 Any other acute illness which need rescue medication. 
DURATION OF TREATMENT: 
          48 days. 
EVALUATION OF CLINICAL PARAMETERS: 
The history includes past, personal, family, occupation, dietary habits, 
seasonal history, and associated history. 
CLINICAL INVESTIGATIONS: 
BLOOD: 
            TC, DC, ESR, Hb , Sugar, Urea, 
Serum Creatinine, Cholesterol, Bleeding time, Clotting time.       
URINE: 
Albumin, Sugar, Deposit 
MOTION: 
 Occult blood, ova, cyst 
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SPECIFIC INVESTIGATIONS 
    Proctoscopy 
SIDDHA ASSESSMENTS: 
  Envagai thervugal 
  Neerkuri 
  Neikkuri 
A case sheet format was prepared on the basis of the Siddha methodology ex: 
Envagai thervvugal, Mukkutram, Nilam, Kaalam, Udal thathukkal, including 
Neerkuri and Neikuri. Individual case sheet was maintained for each patient at 
outpatient department. 
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RESULTS  AND  OBSERVATIONS 
 
 The study on Ratthamoolam was carried out in 40 patients in the Department 
of Pothu Maruthuvam, Government Siddha Medical College, Chennai-106 attached to 
Arignar Anna hospital during 2015-2017 were analyzed. The observation were made 
and tabulated with following criteria.  
 Age Distribution 
 Gender Distribution 
 Occupational status 
 Socio economic status  
 Dietary habits 
 Seasonal occurrence  
 Thinai 
 Mukkutram- Vatham, Pitham, Kabam 
 EzhuUdalKattugal 
 EnvagaiThervugal 
 Naadi 
 Neikuri 
 Grading of Results 
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AGE DISTRIBUTION 
 
S.No AGE IN YEARS 
NUMBER OF 
CASES 
PERCENTAGE (%) 
1 20 - 30 yrs 7 17.5% 
2 31 - 40 yrs 17 42.5% 
3 41 - 50 yrs 12 30% 
4 51 - 60 yrs 4 10% 
 
 
 
 
Inference:  
According to the above mentioned data, 7 patients (17.5%) were in age group 
of 20-30 years,  17 patients (42.5% ) were in age group of 31-40 years, 12 patients 
(30%) were in age group of 41-50 years, 4  patients (10%) were in age group of 51-60 
years. 
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GENDER DISTRIBUTION 
 
 
 
S. No GENDER NUMBER OF CASES PERCENTAGE (%) 
1 Male 19 47.5% 
2 Female 21 52.5% 
 
 
 
 
 
 
Inference 
 About 19 patients (47.5%) were males and 21 patients (52.5%) were females. 
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OCCUPATION 
S.No OCCUPATION 
NUMBER OF 
CASES 
PERCENTAGE 
(%) 
1 Office worker 11 27.5% 
2 House Wife 9 22.5% 
3 Business 3 7.5% 
4 Coolie 5 12.5% 
5 Student 2 5% 
6 Tailor 3 7.5% 
7 Nurse 1 2.5% 
8 Police 1 2.5% 
9 Driver 5 12.5% 
 
 
Inference:  
Out of 40 patients, 11 patients (27.5%) were Office workers, 9 patients 
(22.5%) were House wives.  3 patients (7.5%) were Business persons. 5 patients 
(12.5%) were Coolie labourers, 2 patients (5%) were Students, 3 patients (7.5%) were 
Tailors, 1 patient (2.5%) was Nurse, 1 patient (2.5%) was Police and 5 patients 
(12.5%) were Drivers. 
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SOCIO ECONOMIC STATUS 
 
S. No 
SOCIO – ECONOMIC 
STATUS 
NUMBER OF 
CASES 
PERCENTAGE 
(%) 
1 
Low Income 
( below 2 Lakh per annum) 
29 72.5% 
2 
Middle Income 
(2 -  5 Lakh  per annum) 
8 20% 
3 
High Income 
( Above 5 Lakh per annum) 
3 7.5% 
 
 
 
 
Inference: 
 Among 40 cases 29 cases (72.5%)  comes under low economic status, 8 cases 
(20%) of them under moderate status and 3 cases (7.5%) of them under high income 
status. 
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DIETARY HABITS 
 
S.No DIET 
NUMBER OF 
CASES 
PERCENTAGE 
(%) 
1 Vegetarian 7 17.5% 
2 Mixed diet 33 82.5% 
 
 
 
 
Inference 
 Among 40 patients, 7 patients (17.5%) were taking vegetarian food and 33 
patients (82.5%) were taking mixed diet. 
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SEASONAL OCCURRENCE 
S.No KAALAM (Season) NUMBER OF CASES PERCENTAGE (%) 
1 
Kar kaalam 
(Aug 17 – Oct 16, 2016) 
6 15 % 
2 
koothir Kaalam 
(Oct 17 – Dec 15, 2016) 
10 25 % 
3 
Munpani kaalam 
(Dec 16,2016 – Feb 12, 
2017) 
13 32.5 % 
4 
Pinpani kaalam 
(Feb 13 – Apr 13) 
11 27.5 % 
5 
Elavenir kaalam 
(Apr 14 – Jun 14, 2017) 
0 0 % 
6 
Muthuvenir kaalam 
(Jun 15 – Aug 16, 2017) 
0 0 % 
 
 
Inference 
 In paruvakaalam highest incident of cases, 13 cases (32.5%) were noted in 
Munpani kaalam , 11 cases (27.5%) were noted in Pinpani kaalam, 10 cases (25%) 
were noted in Koothir kaalam, 6 case (15%) were noted in karkaalam. 
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DISTRIBUTION OF THINAI 
 
S.No THINAI NUMBER OF CASES PERCENTAGE (%) 
1 Kurinji 0 0 % 
2 Mullai 0 0 % 
3 Marutham 9 22.5 % 
4 Neithal 31 77.5 % 
5 Paalai 0 0 % 
 
 
 
Inference: 
 Among 40 cases, 31 cases (77.5%) were from Neithal and 9 cases (22.5%) 
cases were from Marutha nilam 
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DISTRIBUTION OF MUKKUTRAM 
VATHAM 
S.No VATHAM NUMBER OF CASES PERCENTAGE (%) 
1 Pranan 5 12.5% 
2 Abanan 40 100% 
3 Viyanan 0 0% 
4 Uthanan 0 0% 
5 Samanan 0 0% 
6 Nagan 0 0% 
7 Koorman 4 10% 
8 Kirukaran 13 32.5% 
9 Devathathan 0 0% 
10 Thananjeyan - - 
 
 
 
Inference 
Out of 40 patients, Pranan was affected in 5 cases (12.5%), Abanan was 
affected in all the 40 patients (100%), Koorman was affected in 4 cases (10%) and 
Kirukaran was affected in 13 patients (32.5%).  
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PITTHAM 
S.No PITHAM 
NUMBER OF 
CASES 
PERCENTAGE (%) 
1 Analagam 13 32.5% 
2 Ranjagam 14 35% 
3 Saathagam 40 100% 
4 Alosagam 4 10% 
5 Pirasagam 0 0% 
 
 
 
 
 
Inference 
 Among 40 patients, Analaga pitham was affected in 13 patients (32.5%), 
Ranjagam was affected in 14 patients (35%), Saathagam was affected in all the 40 
patients (100%) and Alosagam was affected in 4 cases (10%). 
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DISTRIBUTION OF KABAM 
 
S.No KABHAM 
NUMBER OF 
CASES 
PERCENTAGE 
(%) 
1 Avalambagam 0 0% 
2 Klethagam 13 32.5% 
3 Pothagam 0 0% 
4 Tharpagam 0 0% 
5 Santhigam 6 15% 
 
 
 
 
Inference 
 Among the 40 patients, Kilethagam was affected in 13 patients (32.5%) and 
Santhigam 6 patients (15%). 
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UDAL THATHUKKAL 
 
S.No 
EZHU UDAL 
THATHUKAL 
NUMBER OF 
CASES 
PERCENTAGE (%) 
1 Saaram 40 100% 
2 Senneer 14 35% 
3 Oon 0 0% 
4 Kozhupu 0 0% 
5 Enbu 6 15% 
6 Moolai 0 0% 
7 Sukkilam /Suronitham 0 0% 
 
 
 
 
Inference 
 Among the 40 patients, Saaram was affected in all the 40 cases (100%), 
Senneer was affected in 14 cases (35%) and Enbu was affected in 6 cases (15%). 
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EN VAGAI THERVUGAL 
 
S.No 
EN VAGAI 
THERVUGAL 
NUMBER OF 
CASES 
PERCENTAGE (%) 
 Nadi 40 100% 
1 Sparism 0 0 
2 Naa 14 35% 
3 Niram 0 0% 
4 Mozhi 0 0% 
5 Vizhi 4 10% 
6 Malam 40 100% 
7 Moothiram 0 0% 
 
 
 
Inference 
 Among 40 patients, Nadi was affected in all the 40 patients (100%),   Na was 
affected in 14 cases (35%), Vizhi was affected in 4 patients (10%) and Malam was 
affected in 40 cases (100%).  
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NAADI 
 
S.No NAADI NUMBER OF CASES PERCENTAGE (%) 
1 Vatha pitham 7 17.5% 
2 Pitha vatham 33 82.5% 
 
 
 
 
 
Inference 
 Among the 40 patients, 33 Patients (82.5%) had Pitha Vatha Naadi and 7 
Patients (17.5%) had Vatha Pitha Naadi. 
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NEIKKURI 
 
 
S.No THATHU NEIKURI 
NUMBER OF 
CASES 
PERCENTAGE 
(%) 
1 Vatha neer Spread like snake 12 30% 
2 Pitha neer Spread like ring 26 65% 
3 Kabha neer Spread like pearl 2 5% 
 
 
 
 
Inference 
 Among the urine sample of 40 patients, 26 samples (65%) show Pitha neer, 12 
samples (30%) show Vatha neer and 4 samples (5%) show Kabha neer. 
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GRADATION OF RESULTS 
 
 
S. No Grading of Results No of cases Percentage 
1 Good Improvement 9 22.5% 
2 Moderate Improvement 19 47.5% 
3 Mild Improvement 10 25% 
4 No Improvement 2 5% 
 
 
 
 
Inference 
 Among 40 cases, 9 cases (22.5%) show Good improvement, 19 cases (47.5%) 
show moderate improvement, 10 cases (25%) show Mild improvement and 2 cases 
(5%) show No improvement. 
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LIST OF PATIENTS 
S.No OP  No Age/Sex Occupation 
Date of Medcine  
started 
1. 6950 40/M Auto driver 31.08.2016 
2. 6907 32/F House wife 31.08.2016 
3. 2468 49/M Teacher 05.09.2016 
4. 4564 22/M Student 26.09.2016 
5. 8271 41/F Coolie 14.10.2016 
6. 9550 50/M Auto driver 16.10.2016 
7. 9895 41/M Police 28.11.2016 
8. 675 35/M Tailor 30.11.2016 
9. 731 45/M Coolie 30.11.2016 
10. 1008 33/M Coolie 02.12.2016 
11. 1590 47/M Coolie 05.12.2016 
12. 1589 38/F Teacher 05.12.2016 
13. 2097 52/M Coolie 07.12.2016 
14. 2145 41/F House wife 08.12.2016 
15. 2136 38/M Business man 08.12.2016 
16. 2185 29/F Teacher 08.12.2016 
17. 4568 24/F Engineer 20.12.2016 
18. 5931 32/M Engineer 26.12.2016 
19. 6491 48/F House wife 27.12.2016 
20. 6633 47/F House wife 27.12.2016 
21. 7188 31/F House wife 29.12.2016 
22. 8034 36/F Coolie 02.01.2017 
23. 9276 37/F Nurse 06.01.2017 
24. 351 50/F House wife 10.01.2017 
25. 289 27/M Engineer 10.01.2017 
26. 478 48/M Busines man 11.01.2017 
27. 2241 59/M Driver 20.01.2017 
28. 2747 35/F Coolie 23.01.2017 
29. 3356 38/M Business man 25.01.2017 
30. 8473 27/M Engineer 13.02.2017 
31. 8686 35/F Bank staff 14.02.2017 
32. 9136 20/F Student 15.02.2017 
33. 1265 32/M Tailor 25.02.2017 
34. 1894 30/F Bank staff 25.02.2017 
35. 3631 53/F House wife 03.03.2017 
36. 3978 53/F House wife 04.03.2017 
37. 3942 33/M Tailor 04.03.2017 
38. 3949 32/F House wife 04.03.2017 
39. 5674 36/F House wife 10.03.2017 
40. 8365 41/F House wife 20.03.2017 
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CLINICAL PROGNOSIS 
HEALTH ASSESSMENT QUESTIONNIRE (HAQ) SCORE 
Note: Improvement is assessed based on the difference in HAQ score 
1-6 : Poor/No improvement,  7-12 : Mild improvement 
13-18 : Moderate improvement,  19-24 : Good improvement 
S. No Op no BT AT Difference Prognosis 
1. 6950 16 1 15 Moderate 
2. 6907 19 5 14 Moderate 
3. 2468 15 8 7 Mild 
4. 4564 16 14 2 Poor 
5. 8271 12 0 12 Mild 
6. 9550 15 2 13 Moderate 
7. 9895 20 7 13 Moderate 
8. 675 19 0 19 Good 
9. 731 13 0 13 Moderate 
10. 1008 17 2 15 Moderate 
11. 1590 14 1 13 Moderate 
12. 1589 12 1 11 Mild 
13. 2097 20 1 19 Good 
14. 2145 14 5 9 Mild 
15. 2136 16 1 16 Moderate 
16. 2185 18 12 6 Poor 
17. 4568 19 0 19 Good 
18. 5931 15 0 15 Moderate 
19. 6491 10 0 10 Mild 
20. 6633 17 0 17 Moderate 
21. 7188 20 0 20 Good 
22. 8034 11 2 9 Mild 
23. 9276 19 0 19 Good 
24. 351 15 2 13 Moderate 
25. 289 14 1 13 Moderate 
26. 478 20 1 19 Good 
27. 2241 12 2 10 Mild 
28. 2747 17 2 15 Moderate 
29. 3356 18 2 16 Moderate 
30. 8473 20 1 19 Good 
31. 8686 14 0 14 Moderate 
32. 9136 19 8 11 Mild 
33. 1265 19 0 19 Good 
34. 1894 14 1 13 Moderate 
35. 3631 15 1 14 Moderate 
36. 3978 14 0 14 Moderate 
37. 3942 21 1 20 Good 
38. 3949 15 0 15 Moderate 
39. 5674 14 6 8 Mild 
40. 8365 19 0 19 Good 
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LABORATORY INVESTIGATIONS OF PATIENTS 
 
 
S.No 
Op  
No 
Age 
Before treatment After Treatment ESR (mm) Hb 
(gms%) 
Urine analysis 
TC 
(cu/ 
mm 
DC TC 
(cu/ 
mm) 
DC BT AT BT AT 
P% L% E% P% L% E% 
½ 
hr 
1 
hr 
½ 
hr 
1 
hr 
BT AT Alb Sug Dep Alb Sug Dep 
1 6950 40/M 9700 56 38 6 9800 56 38 6 3 8 3 7 12.4 12.8 N N FE N N N 
2 6907 32/F 9600 54 42 4 9900 54 43 3 5 16 5 12 11.2 11.5 N N N N N N 
3 2468 49/M 9800 59 34 7 9900 62 32 6 4 8 4 6 12.6 12.9 N N N N N N 
4 4564 22/M 9600 55 39 6 9800 55 40 5 25 50 20 40 11.8 11.1 N N FE N N FE 
5 8271 41/F 9400 60 34 6 9500 58 38 4 8 16 10 20 9.2 10.8 N N FE N N FE 
6 9550 50/M 8100 61 35 4 8200 61 36 3 5 12 08 20 12.8 12.9 N N N N N N 
7 9895 41/M 8400 54 44 2 8800 58 39 3 2 6 3 6 10.5 11.3 N N FE N N FE 
8 675 35/M 9600 62 35 3 9700 60 37 3 10 25 8 18 12.8 13.5 N N FE N N FE 
9 731 45/M 8200 60 36 4 8600 58 40 2 13 22 10 18 13.4 14.4 N N N N N N 
10 1008 33/M 8600 51 45 4 8500 60 33 7 2 3 2 3 12.1 12.5 N N FE N N FE 
11 1590 47/M 9200 58 36 6 9300 56 36 4 4 9 3 8 11.4 12.6 N N N N N N 
12 1589 38/F 8300 55 41 4 9400 59 37 4 3 7 3 6 9.7 11.2 N N FE N N N 
13 2097 52/M 7500 56 40 4 7500 55 42 3 10 23 10 21 10.2 10.4 N N N N N FE 
14 2145 41/F 9100 51 46 3 9500 53 41 6 2 5 4 6 9.6 10.8 N N FE N N N 
15 2136 38/M 9700 52 43 5 9900 52 43 5 8 20 9 20 12.7 13.2 N N FE N N N 
16 2185 29/F 7850 55 39 6 7950 54 40 6 10 18 12 26 9.4 8.5 N N FE N N N 
17 4568 24/F 8500 59 36 5 8800 59 39 2 15 35 16 37 9.3 11.1 N N FE N N N 
18 5931 32/M 6900 55 42 3 6900 56 40 4 4 12 18 20 12.5 12.9 N N FE N N N 
19 6491 48/F 9600 55 39 6 9700 55 39 6 16 34 15 32 10.7 10.8 N N FE N N N 
20 6633 47/F 9100 60 38 2 9300 54 40 6 16 36 13 25 8.2 10.6 N N FE N N FE 
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BT – Before Treatment,  AT – After Treatment,  N – Nil, TC – Total Blood Count,  DC – Differential Blood Count, P – Polymorphs, L – Leucocytes,  
E – Eosinophils 
ESR – Erythrocytes Sedimentation Rate,  mm – Milli meter, Hb – Hemoglobin, Alb – Albumin, Sug – Sugar, Dep– Deposits, FE – Few Epithelial cells, FP – Few 
Pus cells, N – Nil. 
21 7188 31/F 8900 61 35 4 9100 60 39 1 5 12 8 20 9.8 11.2 N N N N N N 
22 8034 36/F 7300 56 40 4 8200 57 40 3 2 6 8 15 11.2 11.8 N N N N N N 
23 9276 37/F 9200 62 35 3 9500 60 37 3 10 25 8 26 9.1 11.2 N N FE N N FE 
24 351 50/F 9100 60 35 5 9300 54 40 6 16 36 13 25 8.4 10.5 N N FE N N FE 
25 289 27/M 8900 61 34 5 9000 60 33 7 8 18 12 23 12.6 13.1 N N FE N N FE 
26 478 48/M 7200 56 42 2 8100 56 41 3 3 9 8 15 13.2 13.5 N N N N N N 
27 2241 59/M 6700 59 35 6 7700 54 41 5 10 18 12 26 11.4 13.2 N N FE N N N 
28 2747 35/F 7800 51 45 4 7900 60 36 4 2 3 2 3 8.3 11.1 N N FE N N FE 
29 3356 38/M 7900 56 40 4 8000 55 42 3 3 7 12 16 12.5 12.7 N N FE N N FE 
30 8473 27/M 8100 60 36 4 8600 58 40 2 13 22 10 18 12.1 12.9 N N N N N N 
31 8686 35/F 9300 54 42 4 9600 54 43 3 5 16 5 12 11.5 12.7 N N N N N N 
32 9136 20/F 7600 56 40 4 7400 52 44 4 12 23 14 21 9.5 9.7 N N N N N FE 
33 1265 32/M 9600 62 35 3 9500 60 38 2 10 25 8 18 10.7 12.1 N N FE N N FE 
34 1894 30/F 8600 54 40 6 8600 53 41 6 2 6 3 6 10.6 10.9 N N FE N N FE 
35 3631 53/F 7600 56 40 4 7900 52 45 3 20 23 16 18 11.2 11.6 N N N N N FE 
36 3978 53/F 9200 60 38 2 9800 54 40 6 16 36 13 25 10.8 11.7 N N FE N N FE 
37 3942 33/M 8200 56 40 4 8200 54 42 4 5 12 8 20 13.4 14.2 N N FE N N FE 
38 3949 32/F 7100 62 34 4 7700 60 33 7 2 5 10 15 11.3 11.8 N N N N N N 
39 5674 36/F 7800 57 39 4 7900 55 40 5 6 12 9 18 9.7 11.4 N N FE N N FE 
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BLEEDING TIME AND CLOTTING TIME 
S. No O.P.NO AGE BLEEDING TIME CLOTTING TIME 
BT AT BT AT 
1. 6950 40/M 2’ 20” 2’ 20” 3’ 45” 3’ 45” 
2. 6907 32/F 1’ 50” 1’ 50” 2’ 45” 2’ 45” 
3. 2468 49/M 2’ 15” 2’ 15” 4’ 4’ 
4. 4564 22/M 3’ 25” 3’ 25” 4’ 15”  4’ 15”  
5. 8271 41/F 2’ 30” 2’ 30” 4’ 15” 4’ 15” 
6. 9550 50/M 1’ 45” 1’ 45” 3’ 30” 3’ 30” 
7. 9895 41/M 2’ 50” 2’ 50” 4’ 45” 4’ 45” 
8. 675 35/M 3’ 45” 3’ 45” 3’ 50” 3’ 50” 
9. 731 45/M 1’ 50” 1’ 50” 2’ 25” 2’ 25” 
10. 1008 33/M 2’ 45” 2’ 45” 3’ 40” 3’ 40” 
11. 1590 47/M 3’ 20” 3’ 20” 5’ 45” 5’ 45” 
12. 1589 38/F 2’ 45” 2’ 45” 4’ 4’ 
13. 2097 52/M 3’ 10” 3’ 10” 3’ 45” 3’ 45” 
14. 2145 41/F 2’ 50” 2’ 50” 3’ 3’ 
15. 2136 38/M 3’ 50” 3’ 50” 5’ 40” 5’ 40” 
16. 2185 29/F 3’ 25” 3’ 25” 4’ 20” 4’ 20” 
17. 4568 24/F 2’ 15” 2’ 15” 3’ 40 “ 3’ 40 “ 
18. 5931 32/M 4’ 4’ 5’ 50” 5’ 50” 
19. 6491 48/F 3’ 30” 3’ 30” 3’ 50” 3’ 50” 
20. 6633 47/F 2’ 25” 2’ 25” 3’ 45” 3’ 45” 
21 7188 31/F 2’ 45” 2’ 45” 3’ 25” 3’ 25” 
22 8034 36/F 3’ 50” 3’ 50” 5’ 45” 5’ 45” 
23 9276 37/F 3’ 35” 3’ 35” 4’ 30” 4’ 30” 
24 351 50/F 3’ 45” 3’ 45” 4’ 50” 4’ 50” 
25 289 27/M 2’ 20” 2’ 20” 4’ 4’ 
26 478 48/M 3’ 3’ 4’ 20” 4’ 20” 
27 2241 59/M 3’ 40” 3’ 40” 5’ 40” 5’ 40” 
28 2747 35/F 3’ 45” 3’ 45” 4’ 50” 4’ 50” 
29 3356 38/M 4’ 50” 4’ 50” 5’ 10” 5’ 10” 
LABORATORY INVESTIGATIONS 
 
A Study On Ratthamoolam With The Evaluation Of Siddha Drug Moolaroga Chooranam Page 72 
 
30 8473 27/M 2’ 30” 2’ 30” 3’ 25” 3’ 25” 
31 8686 35/F 3’ 10” 3’ 10” 5’ 10” 5’ 10” 
32 9136 20/F 4’ 4’ 5’ 15” 5’ 15” 
33 1265 32/M 1’ 50” 1’ 50” 3’ 20” 3’ 20” 
34 1894 30/F 3’ 25”  3’ 25”  4’ 10” 4’ 10” 
35 3631 53/F 2’ 50” 2’ 50” 3’ 40” 3’ 40” 
36 3978 53/F 4’ 10” 4’ 10” 4’ 50” 4’ 50” 
37 3942 33/M 3’ 25” 3’ 25” 3’ 55” 3’ 55” 
38 3949 32/F 2’ 15” 2’ 15” 3’ 50” 3’ 50” 
39 5674 36/F 3’ 30” 3’ 30” 3’ 45” 3’ 45” 
40 8365 41/F 2’ 15” 2’ 15” 3’ 10” 3’ 10” 
 
Note: BT- Before Treatment AT- After Treatment 
  
 
 
 
DISCUSSION 
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DISCUSSION 
 RATTHA MOOLAM, is a clinical entity described by Yugi munivar in his 
Yugi Vaidhya Chinthamani 800. The classical symptoms are Bleeding per rectum, 
Constipation, and loss of appetite. These features can be well compared with 1
st
degree 
haemorroids. 
 40 patients are selected in the Department of Pothumaruthuvam , Government 
Siddha medical college, attached to Arignar Anna Hospital, Arumbakkam, Chennai-
106. 
All necessary investigations were carried out to all patients and trial medicine 
was given. The results of before and after treatment of all patients were analysed and 
discussed as below. 
IEC and CTRI APPROVAL 
The study was approved by Institutional Ethical Committee (IEC) and the 
approval number is GSMC – CH-ME-4/2015/002. It was also approved by Clinical 
Trials Registry of India (CTRI) and the CTRI registration number is 
CTRI/2017/05/008568. 
DRUG AUTHENTICATION 
 All the raw drugs  were collected from their native places. Its organoleptic 
characters, microscopic and macroscopic examination were conducted and 
authenticated by Head of the Department, Dept of botany, Govt Siddha Medical 
College, Arumbakkam, Chennai 106. 
IAEC APPROVAL 
 The trial drug got IAEC approval for Toxicological and Pharmacological 
Studies at Sathyabama University, Chennai. The Approval number is 
SU/CLATR/IAEC/IV/020/2016 and SU/CLATR/IAEC/VII/045/2016 
TOXICOLOGICAL STUDY:  
 Acute oral toxicity study followed as per OECD 423 guidelines and Sub acute 
oral toxicity study done as per OECD 407 guidelines revealed no toxicity in the trial 
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medicine. There is no change between control and test group of animals in Serological 
and Hematological parameters. In Histopathological study no abnormalities were 
found in cells. This shows that the drug is safe. 
PHARMACOLOGICAL STUDY:  
Pharmacological activity of Moolaroga chooranam is screened against Aspirin 
induced bleeding time prolongation in Wistar Albino rats. The study show that there 
is significant change in Bleeding time and Clotting time. 
PHYSICO CHEMICAL ANALYSIS 
 Loss on drying  - 5.13% 
 Total ash   - 16.46% 
 Water soluble ash  - 11.78% 
 Acid soluble ash  - 4.35% 
 Water soluble extractive - 14.70% 
 Alcohol soluble extractive - 7.80% 
 pH value   - 6.96 
BIOCHEMICAL ANALYSIS 
 Moolaroga chooranam contains 
 Acid Radicals: Sulphide, Phosphate 
 Basic Radicals: Reducing sugar, Iron 
CLINICAL STUDY 
AGE DISTRIBUTION: 
 Out of 40 cases, high incidences of cases (42.5%) were noted in age group 
ranging from 31-40 years. Hemorrhoids generally occur in 30 to 50 years age group. 
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GENDER DISTRIBUTION 
 About 47.5% were males and 52.5% were females. 
OCCUPATION: 
Out of 40 patients, 11 patients (27.5%) were Office workers, 9 patients 
(22.5%) were House wives.  3 patients (7.5%) were Business persons. 5 patients 
(12.5%) were Coolie labourers, 2 patients (5%) were Students, 3 patients (7.5%) were 
Tailors, 1 patient (2.5%) was Nurse, 1 patient (2.5%) was Police and 5 patients 
(12.5%) were Drivers. Hemorrhoids usually occur among drivers, tailors who are 
constantly sitting during work. Here least number of those cases were recorded which 
may be due to low sample size. 
SOCIO ECONOMIC STATUS 
 Among 40 cases 72.5% comes under low economic status, 8 cases (20%) of 
them under moderate status and 3 cases (7.5%) of them under high income status. 
KAALAM: (SEASON) 
 In paruvakaalam highest incident of cases, 13 cases (32.5%) were noted in 
Munpani kaalam , 11 cases (27.5%) were noted in Pinpani kaalam, 10 cases (25%) 
were noted in Koothir kaalam, 6 case (15%) were noted in karkaalam. Though 
Rathamoolam generally aggravates in hot seasons it could also occurs in all seasons. 
THINAI:  
 Among 40 cases most of the cases (31 cases) i.e 77.5%  were from Neithal 
nilam. Though Rathamoolam occurs in all lands. Here 77.5 %  cases belong to Neithal 
Nilam is due to locality of the study i.e. Chennai.  
DIET: 
Among 40 patients, 7 patients (17.5%) were taking vegetarian food and 33 
patients (82.5%) were taking mixed diet. Rough western diet and consuming spicy 
foods are important cause for Rathamoolam. 
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PERSONAL HABITS: 
 Regarding personal habits, 6 patients (15%) were smokers, 3 patients (7.5%) 
were alcoholic, 2 patients (5%) were tobacco chewer, and 29 patients (72.5%) were 
none of the above. Majority of cases comes under none of the above. 
OBSERVATION OF ALTERED MUKKUTRAM 
VATHAM: 
Out of 40 patients, Pranan was affected in 5 cases (12.5%), Abanan was 
affected in all the 40 patients (100%), Koorman was affected in 4 cases (10%) and 
Kirukaran was affected in 13 patients (32.5%). Abanan was affected due to 
constipation. Kirukaran was affected due to loss of appetite. 
PITHAM: 
Among 40 patients, Analaga pitham was affected in 13 patients (32.5%), 
Ranjagam was affected in 14 patients (35%), Saathagam was affected in all the 40 
patients (100%) and Alosagam was affected in 4 cases (10%). Ranjagam was affected 
because of Pallor / anemia due to bleeding. 
KABHAM: 
Among the 40 patients, Kilethagam was affected in 13 patients (32.5%) and 
Santhigam 6 patients (15%). In Rattha moolam, Kilethagam was affected because of 
loss of appetite. 
EZHU UDAL KATTUGAL: 
Among the 40 patients, Saaram was affected in all the 40 cases (100%), 
Senneer was affected in 14 cases (35%) and Enbu was affected in 6 cases (15%). In 
Rattha moolam, Senneer was affected because of bleeding.  
ENVAGAI THERVU: 
 Among 40 patients, Nadi was affected in all the 40 patients (100%),   Na was 
affected in 14 cases (35%), Vizhi was affected in 4 patients (10%) and Malam was 
affected in 40 cases (100%). Na was affected due to anemia caused by bleeding.  
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NAADI: 
Among the 40 patients, 33 Patients (82.5%) had Pitha Vatha Naadi and 7 
Patients (17.5%) had Vatha Pitha Naadi. 
NEIKURI:  
Among the urine sample of 40 patients, 26 samples (65%) show Pitha neer, 12 
samples (30%) show Vatha neer and 4 samples (5%) show Kabha neer. 
INVESTIGATIONS: 
 Investigations like TC, DC, ESR, Hb, Bleeding time, Clotting time, Blood 
sugar, Serum cholesterol, Blood urea, Serum creatinine, were examined and urine 
analysis for albumin, sugar and deposits were also examined. 
CLINICAL STUDY: 
 Treatment was given with the trial drug Moolaroga chooranam. 
Dose  : 1 gram, twice a day, with honey after food. 
Duration : 48 days. 
IMPROVEMENT 
 Clinical symptoms before and after treatment were noted. All were patients 
were given score based on Health Assessment Questionnaire (HAQ). The difference 
between the HAQ score before and after treatment is taken as improvement. 
GRADING OF RESULTS: 
 Among 40 cases, 9 cases (22.5%) show Good improvement, 19 cases (47.5%) 
show moderate improvement, 10 cases (25%) show Mild improvement and 2 cases 
(5%) show No improvement. 
BIO-STATISTICAL ANALYSIS 
 Since the P value is highly significant (<0.0001), the null hypothesis is not 
accepted. So the treatment was significantly improving the HAQ score among the 
patients for the treatment of Ratthamoolam. 
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SUMMARY 
The clinical study on RATTHA MOOLAM was carried out in Post graduate 
department of Maruthuvam, Government Siddha Medical College, Aringar Anna 
Hospital, Chennai – 106 during the period of 2015-2017. 
A total of 40 patients were treated in the Outpatient department. The clinical 
and pathological assessment was carried out on the basis of Siddha and Modern 
aspects. 
All the patients were treated with MOOLAROGA CHOORANAM, 1 Gm, 
daily with Honey for a duration of 48 days. 
 The Toxicological studies of the trial medicine reveal no toxicity. 
 The pharmacological studies reveal that, the trial drug has good styptic activity 
in rat models. 
 Most of the patients were in the age group between 31-40 years (42.5%) 
 Most of the patients were from Neithal nilam 77.5%. 
 Most of the patients were Office workers (27.5%) and home makers (22.5%) 
 Among 40 cases 72.5% comes under low economic status category 
 Among 40 patients, 7 patients (17.5%) were taking vegetarian food and 33 
patients (82.5%) were taking mixed diet. 
 In paruvakaalam highest incident of cases, 13 cases (32.5%) were noted in 
Munpani kaalam 
 In Vatham ,Abaanan (100%) was affected in all the cases.  
 In Pitham, Saathagam, Ranjagam, and Analagam were affected in 100%, 35% 
and 32.5% cases respectively. 
 In Iyyam, , Kilethagam was affected in 32.5% of cases. 
 In Ezhu udal thathukkal, Saaram (100%), Seneer(35%) were affected. 
 In Envagai thervu Nadi (100%), malam (100%) and Na (35%) were mostly 
affected.  
 Regarding naadi, Pitha vatha naadi (82.5%) was the most common naadi 
observed. 
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 22.5% of patients show good improvement, 25% of patients shows mild   
improvement and 47.5% patients show moderate improvement and 5% of 
patients the improvement was poor.  
 Bio- statistical analysis of the clinical trial reveals significant p value 
 < 0.0001 and concluded that the treatment is effective and significant. 
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   CONCLUSION 
 The drug, Moolaroga chooranam is a combination of nine herbs having 
astringent, laxative and Anti-inflammatory properties.  
 Most of the ingredients of Moolaroga chooranam are indicated for 
hemorrhoids, which are mentioned in general characteristics in Siddha Materia 
medica. The taste of the trial drug is Astringent.  As Rattha moolam is mainly 
due to the derangement of Pitha kutram, the astringent property of the drug 
neutralizes the Pitha kuttram. So, it is considered as Ethirurai maruthuvam. 
 The drug, Moolaroga chooranam did not show any toxicity in the Toxicological 
studies and thus proved to be safe for human administration. 
 From the Pharmacological studies it is evident that, the trial medicine has 
significant Styptic activity. 
 Treatment improved the functions of abana vaayu, which regularizes the bowel 
habits. 
 No adverse effects were reported during the course of the treatment. 
 The trial medicine gave good relief from the symptoms of Rattha moolam. 
The trial medicine Moolaroga chooranam can give a better solution for 
RATTHAMOOLAM (BLEEDING PILES). Along with the trial drug supportive 
therapies like diet and changing of their lifestyles may control the disease. 
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IAEC CERTIFICATE FOR TOXICOLOGICAL STUDY 
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TOXICOLOGICAL STUDY 
ACUTE TOXICITY STUDY 
Acute toxicity study of the study drug Moolaroga Chooranam was carried out 
as per OECD guideline (Organization for Economic Co-operation and Development) 
Guideline-423. 
Animal 
Healthy adult Wistar albino rat weighing between 170-200 g were used for the 
study.  The animals were housed in poly propylene cages and were kept in well 
ventilated with 100% fresh air by air handling unit (AHU). A 12 light / dark cycle 
were maintained .Room temperature was maintained between 22 + 2
0 
C
 
and relative 
humidity 50–65%. They were provided with food (Sai feeds, Bangalore, India) and 
water ad libitum. All the animals were acclimatized to the laboratory for 7 days prior 
to the start of the study. 
The experimental protocol was approved by The Institutional Animal Ethics 
Committee of Sathyabama University, Chennai, Tamil Nadu, India. 
Acute toxicity Study 
Acute toxicity study will be carried out in accordance with OECD guideline 
423
[50]
. The animals were fasted overnight with free access to water. The study was 
conducted with single oral dose administration of Moolaroga Chooranam.  
IAEC SU/CLATR/IAEC/IV/020/2016 
Animal Grouping 
One group consist of 6 female rats were used for this study. The dose utilized 
for evaluation of acute toxicity study is about 2000 mg/kg higher than that of the 
therapeutic dose.  
Animal Grouping 
GROUP I : Animals received Test drug 2000 mg/kg (p.o)  
The animals were fasted overnight (12- 16 hrs) with free access to water. The 
study was conducted with single oral administration of study drug Moolaroga 
Chooranam 2000mg/kg (p.o). The animals were observed continuously for first 72 h 
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and then 14 days for emerging signs of behavioral changes, body weight changes and 
for mortality. 
Occurrence of toxicity in animals were observed continuously for the first 4 to 
24 h and observed periodically for the next 14 days.  Observation includes the change 
in skin, fur, eyes and mucus membrane. Appearance of C.N.S,C.V.S and A.N.S related 
toxicity such as tremors, convulsions, sedation, steric behavior, respiratory distress, 
cardiovascular collapse, response to sensory stimuli, salivation, diarrhea, lethargy, 
sleep, coma and mortality were observed with special attention.   
Body weight was recorded periodically. At the end of the experiment all 
animals were subjected for gross necropsy and observed for pathological changes. 
SUB-ACUTE TOXICITY STUDY 
Sub-acute toxicity study was carried out as per OECD guidelines Guideline-
407
[51]
. 
Animals 
Healthy adult Wistar albino rat weighing between 170-200 g were used for the 
study.  The animals were housed in poly propylene cages and were kept in well 
ventilated with 100% fresh air by air handling unit (AHU). A 12 light / dark cycle 
were maintained .Room temperature was maintained between 22 + 2
o 
C
 
and relative 
humidity 50–65%. They were provided with food (Sai feeds, Bangalore, India) and 
water ad libitum. All the animals were acclimatized to the laboratory for 7 days prior 
to the start of the study. 
The experimental protocol was approved by The Institutional Animal Ethics 
Committee of Sathyabama University, Chennai, Tamil Nadu, India. 
IAEC SU/CLATR/IAEC/IV/020/2016 
 
Animal Grouping 
Animals were divided into three groups of 06 animals each consist of 3 male 
and 3 female rats. 
GROUP I : Animals received saline 5 ml/kg b.w (p.o)             
GROUP II : Animals received low dose of test drug 200 mg/kg (p.o) 
GROUP III : Animals received high dose of test drug 400 mg/kg (p.o) 
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The animals were randomly divided into control group and drug treated 
groups for two different doses viz. low dose (200 mg/kg b.w) and high dose (400 
mg/kg b.w). 
The animals were administrated with the study drug once daily for 28 days. 
The animals in group I (control group) received normal saline 5 ml/kg b.w. The 
animals in group II received low dose of Moolaroga Chooranam 200 mg/kg b.w (p.o) 
and group III received high dose of Moolaroga Chooranam 400 mg/kg b.w (p.o). 
The rats were weighed periodically and observed for signs of toxicity pertains 
to C.N.S, C.V.S, A.N.S including behavioral changes, food - water intake and 
morphological changes. At the end of 28
th
 day, the animals were fasted for overnight 
with free access to water. On 29
th
 day the animals were sacrificed with excess 
anesthesia. Blood samples were collected from aorta and stored in EDTA 
(ethylenediamine –tetra actate) for Hematological analysis and for serum generation 
for biochemical analysis. 
The vital organs including heart, brain, lungs, spleen, kidneys, liver, stomach, 
testes, and ovary were harvested and carefully examined for gross lesions. The organs 
were preserved in 10% formalin for histopathological assessment and interpretation. 
Hematological analysis 
Blood samples were analyzed using established procedures and automated 
Bayer Hematology analyzer. Parameters evaluated include Packed Cell Volume 
(PCV), Red Blood Cells (RBC) count, White blood cell count (WBC), Platelet Count, 
Hemoglobin (Hb), Mean cell Haemoglobin Concentration (MCHC), Mean Red Cell 
Volume (MCV), Mean Cell Hemoglobin (MCH), Mean platelet volume (MPV), 
Neutrophils, Eosinophil’s, Basophils, Lymphocytes and Monocytes.  
 
Biochemical analysis 
[52]
 
Serum samples were analyzed for High Density Lipoprotein (HDL), Low 
density Lipoprotein (LDL) , Very low density Lipoprotein (VLDL) , Triglycerides 
(TGL), Total Cholesterol , Blood urea nitrogen (BUN), Creatinine, Albumin, Total 
Protein, Glucose, Uric acid, Aspartate Transaminase (AST), Alanine amino 
Transaminase (ALT) and Alkaline  Phosphatase (ALP) using Mind ray auto analyzer 
model BS 120. 
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Histopathological evaluation 
[53]
 
 Organs included of heart, brain, lungs, spleen, kidneys, liver, stomach, testes 
and ovary. Histological slides of organs were made and observed under the 
microscope.  The pathological observations of cross section of these organs were 
performed on gross and microscopic bases. Histological examinations were performed 
on the preserved tissues with particular emphasis on those which showed gross 
pathological changes. 
Statistical analysis 
The statistical analysis was carried by one way ANOVA (GRAPH PAD 
PRISM 5 computer program). Results were expressed as mean ± standard error .A 
statistical comparison was carried out using the Dunnet’s test for the control and 
treatment group.  
Fecal Pellet Analysis 
Methodology 
Rats of control and treatment group were allowed to explore to open field on clean 
and sterile cage with blotting paper. The collected pellets were analyzed for 
consistency, color, Shape, Presence of blood cells etc. 
    
 
Acute Toxicity Study 
Analysis Group I 
Consistency Soft 
Shape Point ended 
Colour Pale green 
Mucous Shedding Absence 
Blood Cells Absent 
Signs of Infection None Observed 
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Sub-Acute Toxicity Study 
Analysis Group I Group II Group III 
Consistency Soft Soft Very Soft 
Shape Oblong Oblong Oblong 
Colour Brownish green Pale green Pale green 
Mucous Shedding Absence Absence Absence 
Blood Cells Absent Absent Absent 
Signs of Infection None Observed None Observed None Observed 
 
 
Muscle Grip Strength Analysis 
Methodology 
The grip strength test is a simple non-invasive method designed to evaluate rat muscle 
force in vivo. Rats of control and drug treated group was allowed to hold the pull bar 
with both the hind limbs firmly then the animal was gently pulled back with the tail 
until the animal lost the grip toward the bar. The procedure was repeated to get the 
average value. Muscle grip ness of the drug treated group was compared to that of the 
control rat to ensure the change in coordination.  
 
Metabolic Cage for Urine Collection 
Rat of control and treatment group was placed individually in metabolic cage with 
free access to feed and water. Urine dropping from the animal was collected using 
specialized wire mesh system fixed at the base of the cage having provision to trap the 
fecal pellet mixed with urine sample. The collected urine sample was subjected to 
analysis with respect to colour, pH, glucose, ketone bodies, pus and blood cells. 
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RESULTS 
Assessment of clinical signs in rats treated with Moolaroga Chooranam on Acute 
toxicity study 
Parameter Group I 
Clinical Signs Parameters 
for the duration of 14 
days 
Test Drug 
2000mg/ Kg    
Number of animals 
observed 6 Female  
Lacrimation Absence 
Salivation Absence 
Animal appearance Normal 
Tonic Movement Absence 
Clonic Movement Absence 
Laxative action Absence 
Touch Response Normal 
Response to Sound 
Normal 
Response 
Response to Light 
Normal 
Response 
Mobility 
Normal 
Response 
Respiratory Distress Nil 
Skin Color Normal 
Stereotype behavior Absence 
Piloerection Absence 
Limb Paralysis Absence 
Posture Normal 
Open field behavior Normal 
Gait Balancing Normal 
Freezing Behaviour Absent 
Sings of Stress and 
Anxiety None Observed 
Muscular coordination Normal 
Muscle grip Normal 
Sedation Absence 
Social Behavior Normal 
Urine Analysis 
No 
Abnormality 
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Urine Colour Yellowish 
Urine pH 7 
Urine -
Glucose                         Absence 
Urine -
Ketones                        Absence 
Urine- 
Bilirubin                         Absence 
Urine-Blood  Cells       Negative 
Urine - Pus cells Negative 
Mortality Nil 
 
Quantitative data on the body weight of rats treated with Moolaroga Chooranam 
in Acute toxicity study 
Group I Before Treatment Weight in Gms After Treatment Weight in Gms 
Mean 
186.7 189.5 
Std. Deviation 
5.354 5.788 
Std. Error 
2.186 2.363 
 
Values are mean ± S.D (n = 6 per group). Control and treatment group were compared 
statistically using one way ANOVA followed by Dunnett’s test. 
 
Assessment of clinical signs in rats treated with Moolaroga Chooranam on Sub-
Acute toxicity study 
Parameter Group I Group II Group III 
Clinical Signs Parameters 
for the duration of 28 
days Control 
Test Drug 
200mg/ Kg    
Test Drug 
400mg/ Kg    
Number of animals 
observed 
3 Male and 3 
Female 
3 Male and 
3 Female 
3 Male and 
3 Female 
Lacrimation Absence Absence Absence 
Salivation Absence Absence Absence 
Animal appearance Normal Normal Normal 
Tonic Movement Absence Absence Absence 
Clonic Movement Absence Absence Absence 
Laxative action Absence Absence Absence 
Touch Response Normal Normal Normal 
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Response to Sound 
Normal 
Response 
Normal 
Response 
Normal 
Response 
Response to Light 
Normal 
Response 
Normal 
Response 
Normal 
Response 
Mobility Normal Normal Normal 
Respiratory Distress Nil Nil Nil 
Skin Color Normal Normal Normal 
Stereotype behavior Absence Absence Absence 
Piloerection Absence Absence Absence 
Limb Paralysis Absence Absence Absence 
Posture Normal Normal Normal 
Open field behavior Normal Normal Normal 
Gait Balancing Normal Normal Normal 
Freezing Behaviour Absent Absent Absent 
Sings of Stress and 
Anxiety 
None 
Observed 
None 
Observed 
None 
Observed 
Muscular coordination Normal Normal Normal 
Muscle grip Normal Normal Normal 
Sedation Absence Absence Absence 
Social Behavior Normal Normal Normal 
Urine Analysis 
No 
Abnormality 
No 
Abnormality 
No 
Abnormality 
Urine Colour Yellowish Yellowish Yellowish 
Urine pH 6 6 6 
Urine -
Glucose                         Absence Absence Absence 
Urine -
Ketones                        Absence Absence Absence 
Urine- 
Bilirubin                         Absence Absence Absence 
Urine-Blood  Cells       Negative Negative Negative 
Urine - Pus cells Negative Negative Negative 
Mortality Nil Nil Nil 
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Effect of Moolaroga Chooranam on Body weight of Rats in Sub-acute toxicity 
study 
Group I Before Treatment Weight in Gms After Treatment Weight in Gms 
Mean 
189.5 193.8 
Std. Deviation 
5.788 5.492 
Std. Error 
2.363 2.242 
Group II Before Treatment Weight in Gms After Treatment Weight in Gms 
Mean 
182.7 197.7 
Std. Deviation 
6.653 5.854 
Std. Error 
2.716 2.39 
Group III Before Treatment After Treatment Weight in Gms 
Mean 
183.7 194.3 
Std. Deviation 
3.724 1.633 
Std. Error 
1.52 0.6667 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control and 
treatment groups were compared statistically using one way ANOVA followed by 
Dunnett’s test. 
 
 
 
Quantitative data on the food and water intake of rats treated with Moolaroga 
Chooranam for 28 days in Sub-acute toxicity study 
GROUP I Food intake Water intake 
Mean 17.33 33.92 
Std. Deviation 3.82 2.727 
Std. Error 1.91 1.363 
GROUP II Food intake Water intake 
Mean 20.17 40.75 
Std. Deviation 3.707 1.287 
Std. Error 1.853 0.6437 
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GROUP III Food intake Water intake 
Mean 18.42 38.25 
Std. Deviation 3.775 2.754 
Std. Error 1.887 1.377 
 
 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control and 
treatment groups were compared statistically using one way ANOVA followed by 
Dunnett’s test. 
 
Effect of Moolaroga Chooranam on Haematology profile of rats in sub-acute 
toxicity study 
GROUP I 
 WBC 
count 
(×10
3
 
µl) 
RBC 
(×10 
6
 
µl) 
PLT 
(×10 
3
 
µl) 
MCV     
(fl) 
MCH    
(pg) 
MCHC 
(g/dl) 
HGB 
(g/dl) 
Mean 12.1 6.867 649.7 64.62 18.48 32.88 12.15 
Std. 
Deviation 1.334 1.084 144.9 2.501 2.137 1.61 1.42 
Std. Error 0.5447 0.4425 59.14 1.021 0.8723 0.6575 0.5795 
GROUP II 
 WBC 
count 
(×10
3
 
µl) 
RBC 
(×10 
6
 
µl) 
PLT 
(×10 
3
 
µl) 
MCV     
(fl) 
MCH    
(pg) 
MCHC 
(g/dl) 
HGB 
(g/dl) 
Mean 11 6.367 888.7 60.67 18.45 32.43 11.75 
Std. 
Deviation 1.527 1.372 135.3 4.949 2.247 1.822 1.148 
Std. Error 0.6234 0.5602 55.23 2.02 0.9175 0.7437 0.4689 
GROUP 
III 
 WBC 
count 
(×10
3
 
µl) 
RBC 
(×10 
6
 
µl) 
PLT 
(×10 
3
 
µl) 
MCV     
(fl) 
MCH    
(pg) 
MCHC 
(g/dl) 
HGB 
(g/dl) 
Mean 10.8 5.633 999.7 56.37 21.9 33.2 12.1 
Std. 
Deviation 1.802 0.7607 146.6 2.594 2.313 1.652 1.293 
Std. Error 0.7358 0.3106 59.83 1.059 0.9445 0.6743 0.5279 
 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control and 
treatment groups were compared statistically using one way ANOVA followed by 
Dunnett’s test. 
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Effect of Moolaroga Chooranam on Haematology profile of rats in sub-acute 
toxicity study 
GROUP I 
Lymph        
(%) 
Mon            
(%) 
Neutrophils     
(X 10
3
/mm
3
) Eosinophils 
(%) 
Basophils 
(%) 
MPV (fl) 
Mean 77.38 3.15 2.517 1.583 0.3333 5.567 
Std. Deviation 7.903 0.8264 0.9196 0.2787 0.5164 1.181 
Std. Error 3.226 0.3374 0.3754 0.1138 0.2108 0.4821 
GROUP II 
Lymph        
(%) 
Mon            
(%) 
Neutrophils     
(X 10
3
/mm
3
) Eosinophils 
(%) 
Basophils 
(%) 
MPV (fl) 
Mean 77.82 3.967 2.017 1.533 0.1667 6.533 
Std. Deviation 7.372 1.492 0.96 0.2733 0.4082 0.8892 
Std. Error 3.01 0.6092 0.3919 0.1116 0.1667 0.363 
GROUP III 
Lymph        
(%) 
Mon            
(%) 
Neutrophils     
(X 10
3
/mm
3
) Eosinophils 
(%) 
Basophils 
(%) 
MPV (fl) 
Mean 79.22 3.633 2.1 1.267 0.1667 5.933 
Std. Deviation 3.311 1.529 0.7616 0.2251 0.4082 1.795 
Std. Error 1.352 0.6243 0.3109 0.09189 0.1667 0.7329 
       Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control and 
treatment groups were compared statistically using one way ANOVA followed by 
Dunnett’s test. 
 
Effect of Moolaroga Chooranam on Serum Bio-chemistry profile of rats in sub-
acute toxicity study 
GROUP I 
Blood 
sugar 
® 
(mg/d
l) 
BUN 
(mg/d
l) 
 Serum 
creatini
ne 
(mg/dl) 
Serum 
total 
choleste
rol 
(mg/dl) 
Serum 
triglyceri
des level 
(mg/dl) 
Serum 
HDL 
choleste
rol 
(mg/dl) 
Serum 
LDL 
choleste
rol 
(mg/dl) 
Serum 
VLDL 
choleste
rol 
(mg/dl) 
Mean 79.83 18.17 0.8333 125.8 88.17 61.67 45 17.57 
Std. 
Deviation 12.17 2.927 0.1862 9.827 13.17 10.89 5.02 3.546 
Std. Error 4.969 1.195 0.07601 4.012 5.375 4.447 2.049 1.447 
GROUP II 
Blood 
sugar 
® 
(mg/d
l) 
BUN 
(mg/d
l) 
 Serum 
creatini
ne 
(mg/dl) 
Serum 
total 
choleste
rol 
(mg/dl) 
Serum 
triglyceri
des level 
(mg/dl) 
Serum 
HDL 
choleste
rol 
(mg/dl) 
Serum 
LDL 
choleste
rol 
(mg/dl) 
Serum 
VLDL 
choleste
rol 
(mg/dl) 
Mean 82.33 18 0.65 120.2 75.83 60.67 35.17 18.92 
Std. 
Deviation 12.97 2.898 0.2074 9.326 7.91 12.4 14.05 2.853 
Std. Error 5.296 1.183 0.08466 3.807 3.229 5.064 5.735 1.165 
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GROUP 
III 
Blood 
sugar 
® 
(mg/d
l) 
BUN 
(mg/d
l) 
 Serum 
creatini
ne 
(mg/dl) 
Serum 
total 
choleste
rol 
(mg/dl) 
Serum 
triglyceri
des level 
(mg/dl) 
Serum 
HDL 
choleste
rol 
(mg/dl) 
Serum 
LDL 
choleste
rol 
(mg/dl) 
Serum 
VLDL 
choleste
rol 
(mg/dl) 
Mean 83.5 17.67 0.6167 119.3 80 55.33 41.33 15.73 
Std. 
Deviation 13.03 2.338 0.3061 15.36 12.57 11.17 16.33 4.305 
Std. Error 5.321 
0.954
5 0.1249 6.27 5.132 4.558 6.667 1.757 
 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control and 
treatment groups were compared statistically using one way ANOVA followed by 
Dunnett’s test. 
 
Effect of Moolaroga Chooranam on Serum Bio-chemistry profile of rats in sub-
acute toxicity study 
GROUP I 
Serum total 
protein (g/dl) 
Serum 
albumin 
(g/dl) 
(AST)  
(IU/ml) 
(ALT) 
(IU/L) 
(ALP) 
(IU/L) 
Mean 3.833 4.183 104 33.67 186 
Std. Deviation 0.432 0.5879 21.16 10.48 41.02 
Std. Error 0.1764 0.24 8.637 4.279 16.75 
GROUP II 
Serum total 
protein (g/dl) 
Serum 
albumin 
(g/dl) 
(AST)  
(IU/ml) 
(ALT) 
(IU/L) 
(ALP) 
(IU/L) 
Mean 5.117 4.05 132.3 24.83 146.8 
Std. Deviation 0.9704 0.4231 9.309 11.02 36.47 
Std. Error 0.3962 0.1727 3.801 4.498 14.89 
GROUP III 
Serum total 
protein (g/dl) 
Serum 
albumin 
(g/dl) 
(AST)  
(IU/ml) 
(ALT) 
(IU/L) 
(ALP) 
(IU/L) 
Mean 5.267 3.3 121 37.33 138.2 
Std. Deviation 1.311 0.8414 26.63 7.202 47.82 
Std. Error 0.5352 0.3435 10.87 2.94 19.52 
 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control and 
treatment groups were compared statistically using one way ANOVA followed by 
Dunnett’s test. 
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Organ Gross Observation of rats treated with Moolaroga Chooranam for 28 days 
in Sub-acute toxicity study. 
 
Treatment Female 
 
 
 
 
 
Treatment Male 
 
 
Quantitative data on absolute organ weight of rats treated with Moolaroga 
Chooranam for 28 days in Sub-acute toxicity study 
GROU
P I 
HEAR
T 
(gms) 
 
LIVE
R 
(gms) 
KIDNE
YS 
(gms) 
SPLEE
N 
(gms) 
BRAI
N   
(gms) 
LUN
G    
(gms) 
STOMA
CH               
(gms) 
TEST
ES 
(gms) 
UTER
US & 
OVAR
Y 
(gms) 
Mean 0.6833 6.335 1.607 0.5167 1.567 1.683 1.25 3.067 1.167 
Std. 
Dev 0.1065 1.142 0.2337 0.1941 0.216 
0.172
2 0.345 1.172 0.05774 
Std. 
Error 
0.0434
9 
0.466
3 0.09542 
0.0792
3 
0.088
19 
0.070
32 0.1408 0.6766 0.03333 
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GROU
P II 
HEAR
T 
(gms) 
 
LIVE
R 
(gms) 
KIDNE
YS 
(gms) 
SPLEE
N 
(gms) 
BRAI
N   
(gms) 
LUN
G    
(gms) 
STOMA
CH               
(gms) 
TEST
ES 
(gms) 
UTER
US & 
OVAR
Y 
(gms) 
Mean 0.7683 5.59 1.28 0.6 1.767 1.683 1.333 3.933 1.4 
Std. 
Dev 0.1719 1.16 0.1002 0.1897 
0.150
6 
0.292
7 0.3882 0.7234 0.1 
Std. 
Error 
0.0701
6 
0.473
7 0.04091 
0.0774
6 
0.061
46 
0.119
5 0.1585 0.4177 0.05774 
GROU
P III 
HEAR
T 
(gms) 
 
LIVE
R 
(gms) 
KIDNE
YS 
(gms) 
SPLEE
N 
(gms) 
BRAI
N   
(gms) 
LUN
G    
(gms) 
STOMA
CH               
(gms) 
TEST
ES 
(gms) 
UTER
US & 
OVAR
Y 
(gms) 
Mean 0.5833 6.222 1.307 0.5 1.667 1.65 1.45 2.167 1.433 
Std. 
Dev 
0.0700
5 1.446 0.1078 0.2098 
0.206
6 
0.288
1 0.2074 0.5508 0.05774 
Std. 
Error 0.0286 
0.590
1 0.04402 
0.0856
3 
0.084
33 
0.117
6 0.08466 0.318 0.03333 
 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females) for Heart, 
Liver, Kidney, Brain, Spleen, Lung, Stomach.   Values are mean ± S.D (n = 3 per 
group per sex ) for testes , ovary and uterus for Control and treatment groups were 
compared statistically using one way ANOVA followed by Dunnett’s test. 
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Histopathology of Brain (Male Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
           
GROUP I       GROUP II    GROUP III  
High Power Magnification 40X 
 
        
GROUP I       GROUP II    GROUP III  
 
 
 
Histopathology of Heart (Male Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
 
         
GROUP I       GROUP II   GROUP III  
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High Power Magnification 40X 
 
       
GROUP I       GROUP II    GROUP III  
 
 
Histopathology of Kidney (Male Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
 
   
GROUP I          GROUP II    GROUP III 
High Power Magnification 40X 
 
   
GROUP I       GROUP II    GROUP III  
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Histopathology of Liver (Male Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
 
   
GROUP I          GROUP II        GROUP III  
High Power Magnification 40X 
 
 n   
GROUP I          GROUP II    GROUP III 
 
 
Histopathology of Lung (Male Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
 
   
GROUP I          GROUP II    GROUP III  
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High Power Magnification 40X 
   
GROUP I          GROUP II         GROUP III 
 
 
Histopathology of Spleen (Male Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
 
 
  ’ 
GROUP I          GROUP II    GROUP III 
 
High Power Magnification 40X 
 
     
GROUP I          GROUP II    GROUP III 
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Histopathology of Stomach (Male Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
 
    
GROUP I          GROUP II    GROUP III 
High Power Magnification 40X 
 
    
GROUP I          GROUP II    GROUP III 
 
 
Histopathology of Testes (Male Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
   
   
GROUP I          GROUP II    GROUP III 
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High Power Magnification 40X 
 
   
GROUP I          GROUP II    GROUP III 
 
Histopathology of Brain (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
                  
GROUP I     GROUP II    GROUP III 
High Power Magnification 40X 
  
      
GROUP I      GROUP II    GROUP III  
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Histopathology of Heart (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
      
GROUP I       GROUP II    GROUP III  
High Power Magnification 40X 
 
 
      
GROUP I       GROUP II    GROUP III  
 
 
 
Histopathology of Kidney (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
   
GROUP I       GROUP II    GROUP III  
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High Power Magnification 40X 
 
   
GROUP I      GROUP II    GROUP III  
 
 
Histopathology of Liver (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
 
   
GROUP I          GROUP II    GROUP III 
 
High Power Magnification 40X 
 
    
GROUP I          GROUP II    GROUP III  
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Histopathology of Lung (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
 
   
GROUP I           GROUP II    GROUP III  
 
High Power Magnification 40X 
   
GROUP I           GROUP II    GROUP III  
 
Histopathology of Spleen (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
 
   
GROUP I          GROUP II    GROUP III  
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High Power Magnification 40X 
 
   
GROUP I          GROUP II    GROUP III 
 
 
 
Histopathology of Stomach (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
 
    
GROUP I        GROUP II    GROUP III 
 
 
High Power Magnification 40X 
 
     
GROUP I          GROUP II    GROUP III 
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Histopathology of Uterus (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
 
                       
GROUP I          GROUP II   GROUP III 
 
High Power Magnification 40X 
 
 
 
 
     
GROUP I         GROUP II        GROUP III 
 
 
Histopathology of Ovary (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
 
    
GROUP I          GROUP II    GROUP III 
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High Power Magnification 40X 
 
 
    
GROUP I          GROUP II    GROUP III 
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IAEC CERTIFICATE FOR PHARMACOLOGICAL STUDY 
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PHARMACOLOGICAL STUDY 
Pharmacological Evaluation of styptic activity of Moolaroga chooranam on 
Aspirin induced bleeding time prolongation in rats. 
Name: Dr. B. ANBARASAN 
IAEC: SU/CLATR/IEAC/VII/045/2016 
Animals 
Healthy adult Wistar albino male rats weighing between 200-220 g were used 
for the study.  The animals were housed in poly propylene cages and were kept in 
well ventilated with 100% fresh air by air handling unit. A 12 light / dark cycle were 
maintained .Room temperature was maintained between 22 + 2
o 
C
 
and relative 
humidity 50–65%. They were provided with food (Sai feeds, Bangalore, India) and 
water ad libitum. All the animals were acclimatized to the laboratory for 7 days prior 
to the start of the study. The experimental protocol was approved by The Institutional 
Animal Ethics Committee of Sathyabama University, Chennai, Tamil Nadu, India. 
IAEC: SU/CLATR/IEAC/VII/045/2016 
Experimental Methodology 
The animals were grouped into four groups of 6 animals each. Group I 
(Control group) -received normal saline 5ml/kg, Group II – Aspirin control received 
5mg/kg of aspirin, p.o. for 35 days. Group III - Received Aspirin (5mg/kg) for 21 
days and then treated with 200mg/kg Moolaroga chooranam ,p.o  one hour prior to 
Aspirin administration from day 22 to 35. Group III - Received Aspirin (5mg/kg) for 
21 days and then treated with 400mg/kg Moolaroga chooranam ,p.o  one hour prior to 
Aspirin administration from day 22 to 35. 
Bleeding time prolongation in rats 
Oral administration of Aspirin (5mg/kg),p.o for 21 days will cause significant 
change in the mean bleeding and clotting times. 
Determination of Bleeding Time 
At the end of 35
th
 day bleeding time was evaluated. The tail of the rat was 
warmed for 1min in water at 40°C and then dried. A small cut was made in tail tip 
with a scalpel. Bleeding time start and was noted when the first drop touched the 
circular filter paper and checked at 15 sec intervals until bleeding stops. 
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Determination of Clotting Time 
Clotting time was determined by capillary tube method.  Capillary tube was 
filled with rat blood collected through retro orbital sinus puncture. Tube was broken 
in to small piece for every 15 sec. As soon as threads of fibrin were noticed, the 
stopwatch was stopped and the time recorded as the clotting time for that particular 
rat. 
Prothrombin time (PT) 
0.1 ml of plasma was mixed with 0.2 ml of PT reagent (Calcium thromboplastin) 
and then the reaction mixture was incubated at 37oC, and was absorbed until formation of 
the fibrin clot.  
 
Effect of Moolaroga chooranam on Aspirin induced bleeding time, Clotting time 
and Prothrombin time prolongation in rats. 
Group I 
Bleeding Time in 
Sec 
Clotting Time in 
Sec 
Prothrombin 
time in Sec 
Mean 142.5 125 9.167 
Std. Deviation 31.1 15.49 1.169 
Std. Error 12.7 6.325 0.4773 
Group II 
Bleeding Time in 
Sec 
Clotting Time in 
Sec 
Prothrombin 
time in Sec 
Mean 395 417.5 16.17 
Std. Deviation 24.49 22.08 1.602 
Std. Error 10 9.014 0.654 
Group III 
Bleeding Time in 
Sec 
Clotting Time in 
Sec 
Prothrombin 
time in Sec 
Mean 312.5 335 12.5 
Std. Deviation 17.54 18.17 1.225 
Std. Error 7.159 7.416 0.5 
Group IV 
Bleeding Time in 
Sec 
Clotting Time in 
Sec 
Prothrombin 
time in Sec 
Mean 217.5 277.5 11.67 
Std. Deviation 15.73 22.75 1.506 
Std. Error 6.423 9.287 0.6146 
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Group of animals Bleeding time Clotting time Prothrombin time 
Group I 142.5±31.1 125±15.49 9.167±1.169 
Group II 395±24.49** 417.5±22.08** 16.17±1.602** 
Group III 312.5±17.54** 335±18.17** 12.5±1.225** 
Group IV 217.5±15.73** 277.5±22.75** 11.67±1.506** 
 
Values were expressed as means±S.D for N=6 rats in each group one way 
ANOVA followed by Dunnet’s test. Significant indicates that *P<0.05, **P<0.01 
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Effect of Moolaroga chooranam on Aspirin induced bleeding time, 
Clotting time and Prothrombin time prolongation in rats. 
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Sample Name: Moolaroga Chooranam 
Chloroform Extract 
Stationary Phase - Silica Gel 60 F254 
Mobile Phase – Toluene : Ethyl acetate : Formic acid = 8 : 3: 0.2 
 
 
 
 
 
 
 
         
 
  = 254 nm  
 
 
  = 366 nm  
 
  = 520 nm 
(Derivatized) 
 
Color Rf  value(s) Color Rf  value(s) Color Rf value(s) 
Green 0.14 Red 0.14 Violet 0.08 
Green 0.22 Red 0.18 Green 0.22 
Green 0.25  Red 0.20 Brown 0.25 
Green 0.39 Red 0.22 Violet 0.45 
Green 0.59 Red 0.47 Brown 0.54 
Green 0.70 Red 0.70 Green 0.70 
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HPTLC Chromatogram @ 254 nm:  
 
 
Peak Table @ 254 nm: 
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3D Chromatogram @ 254 nm: 
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BIOCHEMICAL ANALYSIS 
Preparation of sodium carbonate extract: 2 gm of the Moolaroga chooranam is 
mixed with 5 gm of sodium carbonate and taken in a 100 ml beaker and 20ml of 
distilled water is added. Then the solution is boiled for 10 minutes, cooled and then 
filtered. The filtrate is called sodium carbonate extract. 
TEST FOR ACID RADICALS 
S.NO                 EXPERIMENT  OBSERVATION INFERENCE 
1.a Test for Sulphate:  
         2 ml of the above prepared  
extract is taken in a test tube . to this 
add 2ml of 4%  ammonium oxalate 
solution 
Absence of white 
precipitate 
Absence of 
sulphate 
1.b Test for Sulphate:  
        2 ml of the extract is added  with 
2 ml of dilute hydrochloric acid until 
the effervescence ceases off. Then 
2ml of  barium chloride solution is 
added. 
Absence of white 
precipitate 
Absence of 
sulphate 
 
2. Test  for chloride:  
        2ml of extract is added with 
dilute nitric acid till the effervescence 
ceases . then 2ml of silver nitrate 
solution is added. 
Absence of white 
precipitate 
Absence of 
chloride 
3. Test for phosphate:  
        2ml of the extract is treated with 
2ml of ammonium molybdate 
solution and 2ml of concentrated 
nitric acid. 
 
 
Presence of yellow 
precipitate. 
Presence of 
Phosphate 
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4. Test for carbonate:  
        2ml of the extract is treated with 
2ml of magnesium sulphate solution. 
Absence of white 
precipitate. 
Absent 
 
5. Test for sulphide:  
        1gm of the substance is treated 
with 2ml of concentrated 
hydrochloric acid. 
Rotten egg smelling 
is obtained 
Presence of 
Sulphide 
 
6. Test for nitrate:  
         1gm of the substance is heated 
with copper turnings and 
concentrated sulphuric acid and 
viewed the test tube vertically down. 
Absence of reddish 
brown colour. 
Absence of 
Nitrate 
 
7.a Test for fluoride and oxalate:  
          2ml of the extract is added with 
2ml of dilute acetic acid and 2ml of 
calcium chloride solution and heated. 
Absence of white 
precipitate. 
Absence of 
Fluoride and 
oxalate 
 
7.b Test for fluoride and oxalate:  
          5 drops of clear solution is 
added with 2ml of dilute sulphuric 
acid and slightly warmed to this, 1ml 
of dilute potassium permanganate 
solution is added. 
Absence of KMNO4 
solution 
discoloration  
Absence of 
Fluoride and 
oxalate 
 
8. Test for nitrate :  
         3 drops of the extract is placed 
on a filter paper . on that , 2 drops of 
acetic acid and 2 drops of benzidine 
solution is placed. 
Absence of 
yellowish red colour 
. 
Absent 
 
9. Test for borate:  
        2 pinches of the substance is 
made into paste by using sulphuric 
acid and alcohol (95%) and 
introduced into the blue flame. 
Absence of green 
tinged flame 
Absent 
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TEST FOR BASIC RADICALS: 
10. Test for lead:  
          2ml of the extract is added 
with 2ml of potassium iodide 
solution. 
Absence of yellow 
precipitate. 
Absent 
 
11.a Test  for copper:  
         one pinch of the substance is 
made into paste with concentrated 
hydrochloric acid in a watch glass 
and introduced into the luminous 
part of the flame. 
Absence of bluish 
green coloured 
flame is obtained. 
Absent 
 
11.b Test for copper:  
        2ml of the extract is added 
with excess of ammonia solution. 
Absence of deep 
blue  colour 
Absent 
 
12. Test for aluminium:  
         To the 2ml of the extract , 
sodium hydroxide solution is added 
in drops to excess. 
Absence of white 
precipitate. 
Absent 
 
13.a Test for iron: 
          To the 2ml of the extract, 2ml 
of ammonium thiocyanate  soilution 
is added. 
Blood red colour is 
obtained 
Presence of iron 
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13.b Test for iron :  
          To the 2ml of the extract , 
2ml of the ammonium thiocyanate 
solution and 2ml mof concentrated 
nitric acid is added. 
 
 
Blood red colour is 
obtained. 
 
 
Presence of iron 
14. Test for zinc:  
        To the 2ml of the extract , 
sodium hydroxide is added in drops 
to excess. 
Absence of white 
precipitate. 
Absent 
 
15.  Test for calcium:  
         2ml of the extract is added 
with 2ml of 4% ammonium oxalate 
solution. 
Absence of white 
precipitate. 
Absence of 
calcium 
16.  Test for magnesium: 
      To the 2ml of the extract , 
sodium hydroxide is added in drops 
to excess. 
Absence of white 
precipitate. 
Absence of 
magnesium 
 
17. Test for ammonium: 
      2ml of the extract few ml of 
nessler’s reagent and excess of 
sodium hydroxide solution are 
added. 
 Absence of Reddish 
brown precipitate  
Absence of 
ammonium 
 
18.  Test for potassium:    
      A pinch of substance is treated 
with 2ml of sodium nitrite solution 
and then treated with 2ml of cobal 
nitrate in 30% glacial acetic acid. 
Absence of yellow 
precipitate. 
Absence 
potassium 
 
19.  Test for sodium :  
       2 pinches of the substance is 
Absence of yellow 
colour flame. 
Absence of 
sodium 
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made into paste by using 
hydrochloric acid and introduced 
into the blue flame. 
 
20. Test for mercury:  
       2ml of the extract is treated 
with 2ml of sodium hydroxide 
solution. 
 
 
Absence of yellow 
precipitate. 
Absence of 
mercury 
 
21. Test for arsenic : 
       2ml of extract is treated with 
2ml of silver nitrate solution. 
Absence of yellow 
precipitate. 
Absent 
 
 
 
 
22.  Test for starch :  
        2ml of the extract is treated 
with weak iodine solution. 
 
Absence of  blue 
colour. 
Absent 
 
23. Test for reducing sugar :  
       5ml of benedicts qualitative 
solution is taken in a test tube and 
allowed to boil for 2 minutes and 
added 10 drops of the extract and 
again boiled for 2 minutes. The 
colour changes are noted. 
 
 Green colour is 
obtained . 
Presence of 
reducing sugar 
 
24. Test for the alkaloids:  
        2ml of the extract is treated 
with 2ml of the potassium iodide 
solution. 
 
Absence of red 
colour. 
 
 
 
 
 
Absent 
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25. 2ml of the extract is treated with 
2ml of 5%NaOH, well and add 2 
drops of copper sulpate solution. 
Absence of Violet 
colour. 
Absent 
 
 
RESULTS: 
              The trial drug Moolaroga chooranam contains Sulphide, Phosphate in the 
Acid radicals, and Iron and reducing sugar in the basic radicals. 
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INSTITUTIONAL ETHICS COMMITTEE CERTIFICATE 
 
IEC CERTIFICATE 
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BIOSTATISTICS REPORT 
CLINICAL PROGNOSIS 
Health Assessment Score: 
Effect of Moolaroga Chooranam on Health Assessment Score in human subjects 
in the treatment of Rattha Moolam  
S. No BeforeTreatment AfterTreatment 
1. 16 1 
2. 19 5 
3. 15 8 
4. 16 14 
5. 12 0 
6. 15 2 
7. 20 7 
8. 19 0 
9. 13 0 
10. 17 2 
11. 14 1 
12. 12 1 
13. 20 1 
14. 14 5 
15. 16 1 
16. 18 12 
17. 19 0 
18. 15 0 
19. 10 0 
20. 17 0 
21. 20 0 
22. 11 2 
23. 19 0 
24. 15 2 
25. 14 1 
26. 20 1 
27. 12 2 
28. 17 2 
29. 18 2 
30. 20 1 
31. 14 0 
32. 19 8 
33. 19 0 
34. 14 1 
35. 15 1 
36. 14 0 
37. 21 1 
38. 15 0 
39. 14 6 
40. 19 0 
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Software: spss17 version 
Variables: HAQ Score– before treatment, after treatment 
Number of cases: 40 
Test: Paired t test 
Confidence Interval: 95% 
Correlation coefficient (r): 0.09784 
Before and after treatment mean difference ± SEM: 13.925± 4.22 
P Value (2 tailed): p<0.0001. 
t Value: 20.866 
Degrees of freedom: 39 
Inference:  
Since the P value is highly significant (<0.0001), the null hypothesis is not accepted.  
So, the treatment was significantly improving the HAQ Score among the patients for 
the treatment of Ratha Moolam.    
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GOVERNMENT SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE 
CHENNAI – 600 106 
CLINICAL STUDY ON “MOOLAROGA CHOORANAM” IN THE 
TREATMENT OF 
“RATTHA MOOLAM” (BLEEDING PILES) 
INFORMED CONSENT FORM 
“I have read the foregoing information, or it has been read to me. I have 
had the opportunity to ask questions about it and any questions I have asked have 
been answered to my satisfaction. 
            I   consent voluntarily to participate in this study and understand that I have 
the   right to withdraw from the study at any time without in any way it affecting my 
further medical care”. 
"I have received a copy of the information sheet/consent form". 
Date: 
Signature of the participant: 
In case of illiterate participant 
  “I have witnessed the accurate reading of the consent form to the potential 
participant, and the individual has had the opportunity to ask questions. I confirm 
that the individual has given consent freely.”                                                   
Date: 
  
Signature of the witness                                         
 
 
(Selected by the participant bearing no connection with the survey team)       
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Date:    
Station:                                                                                  
Signature of participant:                                                 
Signature of the Co-Investigator: 
 
 Signature of the Principal Investigator:                                   Signature of the HOD 
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CASE SHEET PROFORMA FOR RATTHA MOOLAM 
GOVT.SIDDHA MEDICAL COLLEGE&HOSPITAL, CHENNAI-106 
POST GRADUATE DEPARTMENT BRANCH –I MARUTHUVAM 
Duration: 2015-2017 
 
Op No / Ip No  :    Occupation  : 
Ward No  :    Income  : 
Bed No  :    Nationality  : 
Name   :    Religion  : 
Age   :    D.O.A   : 
Sex   :    D.O.D   : 
Address  :    Diagnosis  : 
 
 
 
 
 
 
1. Complaints and duration  : 
 
 
 
 
 
2. History of present illness  : 
 
 
 
 
3. History of past illness  : 
 
 
4. Personal history   : 
 
 
 
5. Occupational history  : 
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6. Menstrual history   : 
 
 
 
7. Personal Habits   :Veg/nonveg/smoker/Alcocoholic/Tobacco  
  chewer 
 
 
8. Family History   : 
 
 
 
GENERAL EXAMINATION  
Patient consciousness   : 
Body Built    : 
Nourishment    : 
Anaemia    : 
Jaundice    : 
Cyanosis    : 
Clubbing    : 
JVP     : 
Tracheal deviation   : 
Pedal oedema    : 
Lymph adenopathy   : 
 
VITAL SIGNS 
 
Body Temp    : 
Pulse     : 
Respiratory rate   : 
Blood Pressure   : 
Weight    : 
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SIDDHA ASPECT  
NILAM 
Kurinchi  : 
Mullai   : 
Marutham  : 
Neithal  : 
Palai   : 
 
PARUVA KALAM 
Kaar (Aavani, Purattasi)  : 
Koothir (Aippasi, Karthigai)  : 
Munpani (Margazhi, Thai)  : 
Pinpani (Maasi, Panguni)  : 
Elavenil(Sithirai, vaigasi)  : 
Muduenil (aani, aadi)   : 
 
YAAKKAI(Udal) 
Vaatham  : 
Pittham  : 
Kabam   : 
Kalappu  : 
 
GUNAM 
Satthuvam  : 
Rajotham  : 
Thamasam  : 
 
PORI/PULANGAL (SENSORY ORGANS) 
Mei (Sensation)   : 
Vaai (Taste)    : 
Kan (Vision)     : 
Mooku (Smell)    : 
Sevi (Hearing)   : 
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KANMENTHRIYAM/KANNMA VIDAYAM [MOTOR ORGANS] 
Kai (Dhaanam)   : 
Kaal (Kamanam)   : 
Vaai (Vasanam)   : 
Eruvaai (Visarkkam)   : 
Karuvaai (Aanantham   : 
 
UTHKAAYA ATHAKAAYAM 
Puyam (forearm)   : 
Sayam (arm)    : 
Kaal (leg)    : 
Paaatham (feet)   : 
 
UYIR THATHUKKAL 
 
A.VATHAM 
 Piranan   : 
 Abanan   : 
 Viyanan   : 
 Udanan   : 
 Samanan   : 
 Nagan    : 
 Koorman   : 
 Kirukaran   : 
Devathathan   : 
Thananjeyan   : 
 
B.PITHAM 
Anar pitham   : 
Ranjaga pitham  : 
Saathaga pitham  : 
Pirrasaga pitham  : 
Alosaga pitham  : 
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C.KABAM 
Avalambagam   : 
Kilethagam   :  
Pothagam   : 
Tharpagam   : 
Santhigam   : 
 
UDALTHAATHUKKAL 
Saaram   : 
Senner    : 
Oon    : 
Kozhuppu   : 
Enbu    : 
Moolai    : 
Sukkilam/Suronitham  : 
 
ENVAGAI THERVUGAL 
1.Naa    : 
2.Niram   : 
3.Mozhi   : 
4.Vizhi   : 
5.Sparisam   : 
6.Malam   : 
7.Moothiram 
a)Neer Kuri  : 
 b)Nei Kuri  : 
8.Naadi   : 
MALAM 
 Niram    : 
 Edai    : 
 Erugal    : 
 Elagal    : 
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MOOTHIRAM 
 1.Neerkuri 
  Niram   : 
  Manam  : 
  Edai   : 
  Nurai   : 
  Enjal   : 
 2.Neikuri 
 
MODERN ASPECT 
   Sytemic Examination  
 Inspection   : 
 Palpation   : 
 Percussion   : 
 Auscultation   : 
 Proctoscopy   : 
     Others Systems  
 Cardio Vascular System : 
 Respiratory system  : 
 Central nervous system :  
 Genito urinary system  : 
 
 
CLINICAL SIGNS AND SYMPTOMS OF RATTHA MOOLAM 
 
Symptoms 
Before 
Treatment 
After Treatment 
 
7 
days 
14 
days 
21 
days 
28 
days 
35 
days 
42 
days 
48 
days 
Rectal 
Bleeding 
      
  
Pruritus ani         
Constipation         
Loss of 
appetite 
      
  
Giddiness       
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Health Assessment Questionnaire: 
 
I. How often do you have bleeding when passing a motion?    BF      AF 
1. Never    
2. Less than once per week    
3. 1-6 per week    
4. Every day    
 
II. What is the nature of bleeding? 
1. No bleeding    
2. Few drops of blood  
3. Splashing of blood up to 5 ml    
4. Splashing of blood  more than 5 ml    
 
III. How often do you have itching/irritation in the anus? 
1. Never    
2. Less than once per week    
3. 1 – 6 times per week    
4. Every day    
 
IV. How severe is your itching/irritation in anus? 
1. No itching   
2. Mild itching    
3. Moderate itching    
4. Severe itching    
 
V. What is the consistency of the stool during defecation? 
1. Like smooth soft snake    
2. Sausage shape with cracks  
in the surface    
3. Lumpy and sausage like    
4. Separate hard lumps    
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VI. How long do you spend during defecation? 
1. Less than 5 minutes    
2. 5 to 10 minutes    
3. 10 – 15 minutes    
4. More than 15 minutes    
 
 
Total Score 
  
Net Total Score 
(Difference between Total score before  
Treatment And Total score after treatment) 
Note:  Improvement is assessed based on the Difference between Total score 
before treatment And Total score after treatment. 
1 - 6   = No improvement 
7 – 12   = Mild improvement 
13 – 18 = Moderate improvement 
19 – 24  = Good improvement 
 
INVESTIGATIONS 
      1. BLOOD 
 TC 
 DC 
 ESR 
 Bleeding time 
 Clotting time 
 Blood sugar 
 Blood urea 
 Serum cholesterol  
 VDRL 
      2. URINE 
 Albumin 
 Sugar 
 Deposits 
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      3. MOTION 
 Ova 
 Cyst 
 Occult Blood 
 
    4.   SPECIFIC INVESTIGATION 
                       Proctoscopy 
                    
CASE SUMMARY 
 
 
 
 
DIAGNOSIS 
              Rattha moolam 
 
TRIAL DRUG 
             MOOLAROGA CHOORANAM 
 
Dose                                : 1gm, twice a day 
                          
Anubanam                         : Honey 
 
Duration of Treatment       : 48days 
 
 
Pathiam (Do’s and Don’ts): 
 
         DO’S:  
 Drink plenty of water 
 Karunai kilangu 
 Vilangu meen 
 Thuthi keerai 
 Thaali keerai 
 Pasalai keerai 
 Vendhaya keerai 
 Karunaikizhangu 
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 Saenaikizhangu 
 Vendaikkai 
 Atthikkai 
 Kovaikkai  
 Pork 
 Snail should be eaten 
 
 
          Don’ts: 
  Spicy food, chicken should be avoided. 
 
 
 
 
Prognosis at the end of the Treatment 
Prognosis is assessed by Reduction in clinical symptoms and by comparing 
the following parameters before and after treatment. 
1. Bleeding per rectum. 
2. Proctoscopy 
3. Questionairre 
 
 
 
 
Medical Officer      Head of the Department 
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